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This work builds on the use of several Mathematical Modeling tools to develop 
approaches that address relevant, real and previously unanswered questions related to the 
improvement of Public Health Systems, in three particular instances. 
First, this thesis analyzes the variation in state-level vaccination coverage during 
the emergency response to the 2009 H1N1 pandemic influenza outbreak in the United 
States. The analysis considers the overall adults population and two priority sub-
populations: children and high-risk adults. We focus on quantifying the association 
between vaccination coverage and the supply chain and distribution system decisions, 
during the vaccine shortage period, while controlling for other commonly recognized 
factors such as previous vaccinations, socio-economic characteristics, health seeking 
behavior and health infrastructure. The variables analyzed are generally correlated, and 
the problem has a limited sample size with a much larger number of independent 
variables. The findings of this research have been published in Vaccine and presented to 
the Centers for Disease Control and Prevention. 
Second, the research approaches the problem of estimating childhood obesity 
prevalence in small geographic areas in the U. S. Obesity is recognized as one of the 
major health problems in the country, and attending this condition in children is of major 
importance to deal with the sources of the overall problem. The ability to target 
interventions to the most affected children populations is necessary to achieve cost 
effective solutions. But local accurate obesity data is hard to obtain and missing for most 
of the small areas in the country. The research focuses on estimating prevalence of 
 xii 
obesity and overweight status in children in small geographical areas in the absence of 
surveillance and detailed sampling. Our modeling approach is built in two stages. The 
first one uses a logistic regression model that links individual characteristics to high-BMI 
status, and generates samples of the empirical distribution of its coefficients though 
bootstrap re-sampling. The second uses simulation to generate virtual population samples 
of the small areas, which are then combined with the logistic model samples to estimate 
prevalence. Confidence intervals are built though re-sampling. A very important feature 
of our approach is that all of its inputs are from publicly available data, which gives 
availability for the replication of the methodology to any health stakeholder in the US. 
The model estimates were validated by using separate models for adults and children in a 
state with available data. Estimates obtained from our modeling approach were used by a 
large healthcare provider to geographically target interventions for pediatric obesity. 
Third, the thesis presents an introductory analysis of the possible effects of partial 
disruptions to critical supply chains due to absenteeism caused by a generalized flu-like 
illness in the US. For this analysis, we first construct a plausible national food supply 
chain for milk and then we simulate its disruption. To build the supply chain we used 
public information regarding production, consumption, and major milk processors and 
bottlers, and fitted it into a supply network though optimization. Then, to analyze the 
effects of flow disruptions of the supply chain, we built a simulation of the operation of 
the network and virtually generated absenteeism, mildly disrupting the supply chain 
flows by the proportional absences. We used information on potential absenteeism in 
work groups from an influenza simulator. Our initial analysis shows that absenteeism 
may create variations along the supply chain, similar to those described in the bullwhip 
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effect analysis literature, even in the absence of supply shortages and without variations 







 Traditionally, the methodologies used and developed by Industrial and Systems 
Engineering have been built and applied for industrial and commercial practices. It is not 
until recent years that problems in the public health arena are being formally incorporated 
as a new study subject by researchers in this engineering area. Public health systems in 
the United States have a vast number of operations and preparations for possible 
scenarios that will admit much collaboration of research with industrial and other 
engineering areas for years to come. This thesis presents three instances in which 
mathematical tools commonly used in Industrial and Systems Engineering analysis have 
been updated, enhanced, and used for the improvement of public health systems. 
 The first public health systems problem analyzed is aimed to understanding the 
causes of the differences in the state-level vaccination coverage for the Novel H1N1 
Influenza pandemic that affected the US at the end of 2009, and beginning of 2010. This 
study performed an analysis of the relationship between the state-level percentage of 
vaccination in 3 sub-populations (overall adults, high-risk adults and children), and more 
than 180 potential covariates, including many indicators of logistic performance during 
the distribution of the vaccine and supply chain decisions made by each of the state's 
governments. Such an extensive approach became a comprehensive explanation that 
relates vaccination rates with supply chain decisions, while controlling for factors 
commonly related to vaccination. The results were presented to an important public 
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health institution, the Centers for Disease Control and Prevention (CDC) and published 
by Vaccine journal. 
 The findings from the analysis of this historic vaccination effort added up to the 
lessons learned in the aftermath of the massive campaign. Some of the results confirmed 
CDC's educated intuition. But some other findings became apparent only after they were 
exhibited by the study. Some outcomes challenged common decision policies, and 
pointed the way to better practices. The approach presented in the analysis of this first 
problem offers a straight forward way to deal with the technical complications of 
building linear regressions when the number of independent variables is much larger than 
the number of observations, and the independent variables are highly correlated. Chapter 
2 will present the study for overall adults, while chapter 3 will present the analysis on two 
priority subpopulations: children and high-risk adults. 
 The second analysis is related to one of the most relevant public health systems 
problems in our days: Childhood Obesity. Targeting interventions to reduce childhood 
overweight/obesity requires finding those sub-state-level areas where the percentage of 
obese children is higher. But finding prevalence estimators for such small regions is not 
trivial. In fact, there are no previous publications proposing methodologies to estimate 
prevalence of childhood obesity in US small areas for children under 12 years old, other 
than applying direct sampling, physically measuring children, which can be considerably 
expensive. Different from adults, telephonic surveys have proven to be ineffective to 
predict children's obesity status. This thesis presents a modeling strategy that can be used 
to estimate childhood overweight/obesity at a zip code or census tract level using publicly 
available data. 
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 This estimation approach was used in Georgia. The results were found to coincide 
with the state-level point estimation for children 10–17 years old, and the approach was 
validated by comparing outcomes for adults at a county level with those of available 
surveys for Georgia, and outcomes for school age children in Arkansas counties to the 
information obtained in that state by measuring children in schools. This work was used 
by a healthcare provider to target interventions in the state of Georgia, and may provide 
relevant insights for improving more public health systems in the future. Chapter 4 
contains the analysis of this problem. 
 The third and final problem, presented in Chapter 5, analyzes to the possible 
effects of absenteeism due to a generalized flu-like illness to critical supply chains in the 
United States. The first approach considered modeling some food items' supply chains, 
without changes to supplied or demanded quantities. A first set of results shows that 
absenteeism caused by a flu pandemic can cause similar effects to those caused on supply 
chains by changes in supply or demand. We show that tactical responses to shortages 
through the application of inventory and ordering policies and slack capacities across the 
network cause a characteristic distribution of the inventory and service levels across the 
different supply echelons. 
 Industrial and Systems Engineering encompasses an extensive variety of 
mathematical and systemic approaches that can be developed to bring improvement to 
public health systems. It is relevant and necessary that research in industrial engineering, 
related to the different aspects of health related systems, continues its development. 
Hopefully, the present work will serve to foster future related research. 
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CHAPTER 2 
SUPPLY CHAIN AND SYSTEM FACTORS TO EXPLAIN H1N1 
STATE VACCINATION RATES FOR ADULTS IN US EMERGENCY 
RESPONSE TO PANDEMIC 
 
Introduction 
The novel H1N1 influenza virus was detected in the United States in April 2009. 
Worldwide, a pandemic was declared, and a national public health emergency was 
announced in the United States. In the US, plans were made for a national vaccination 
campaign to be rolled out in Fall 2009, when the pandemic H1N1 vaccine would be 
available. The campaign was implemented as a public-private partnership, with federal 
purchase of the vaccine. The Centers for Disease Control and Prevention (CDC) allocated 
vaccine pro rata to states by total population as the vaccine became available. States 
determined how vaccine would be allocated in their jurisdiction and either retained 
control of vaccine allocation to individual providers at the central level or delegated fully 
or partially to local jurisdictions. States or local jurisdictions invited providers to 
participate in the program and vaccine was shipped to designated providers through a 
centralized distribution process supervised by the CDC that built on an existing contract 
for management and distribution of vaccines in the Vaccine for Children (VFC) program. 




Figure 2.1: Scheme of the supply chain of vaccine during the 2009 H1N1 
pandemic response. 
 
State decisions about where to direct vaccine were guided by recommendations of 
the CDC’s Advisory Committee on Immunization Practices (ACIP) (1), which 
recommended that the vaccine be initially directed to: pregnant women, persons who live 
with or provide care for infants aged <6 months, health-care and emergency medical 
services personnel who have direct contact with patients or infectious material, all people 
6 months to 24 years of age, and persons aged 25 through 64 years with certain health 
conditions (“high-risk”). The recommendations also provided further specification of 
priority groups in the event of vaccine shortage and stated that decisions to broaden 




















Figure 2.2: H1N1 Vaccination coverage of adults by state as of January 2010. 
 
 
Overall, more than 120 million doses of vaccine were distributed to over 70 
thousand locations by April 2010 (2-4) and 80.8 million people reported having been 
vaccinated (5). The vaccine supply was insufficient to meet demand initially, and became 
more plentiful after Thanksgiving, a time when demand for influenza vaccination 
traditionally slows. Despite the pro rata allocation of H1N1 vaccine (6), state level 
vaccine coverage rates indicate that there were great differences in coverage across the 
states even when vaccine was in short supply. By the end of January 2010 (7), the 
coverage of adults ranged from 8.7% to 34.4% (Fig. 2.2).  
States varied in their approaches to implementing their H1N1 vaccination 
programs in an unprecedented situation. While the literature addressed factors related to 
uptake of seasonal influenza vaccine at the individual level (8, 9), states and regions used 
their best judgment and knowledge of their jurisdictions to guide their decisions on 
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distribution and system design, given the lack of scientific evidence in that area. The 
purpose of this study was to determine supply chain and system factors associated with 
H1N1 coverage rates at the state-wide level for adults in order to inform future events of 
this nature. 
We hypothesized that characteristics of the vaccine supply chain in each state and 
decisions around targeting vaccine could predict uptake. One classic supply chain study, 
for example, has demonstrated that a product stocked in a large number of locations 
increases the probability that a particular location will be stocked out, and may also 
reduce the distance traveled by the final consumer (10). Some of these characteristics of 
the state vaccine supply included the number of locations where vaccine was available, 
prioritization of the ACIP-recommended target groups, the type of providers to whom 
vaccine was directed, and the lead-time between vaccine allocation and availability in a 
state, which largely reflects differences in states’ ordering processes. 
Because other factors affect uptake, as evidenced by state-to-state variation in 
seasonal influenza coverage and individual-level studies (11-14), underlying population 
differences such as demographic characteristics, utilization of preventive health services, 
and healthcare infrastructure were also examined. It is relevant to mention that 
individual-level studies differ from those with a regional or ecological view. Others have 
used this ecological approach in the analysis of other health-related problems such as 
water fluoridation and tooth decay (15, 16). Data from the centralized distribution system 
on vaccine shipments from October 5, 2009 through December 9, 2009 were made 
available for analysis, thus allowing us to focus the analysis on the period during which 




 The outcome measure is state estimates of vaccination coverage, as calculated by 
the CDC (7). Participants 18 and over on BRFSS and NHFS surveys were asked if they 
had received an H1N1 vaccine during October 2009-January 2010. 
Population and state characteristics 
 From the Census, we identified population (17) and socioeconomic characteristics 
including population size and density, and its composition by age groups, education, 
race/ethnicity, income and poverty, births, and family composition (18). We took 
measures of income inequalities from a study conducted by the University of Connecticut 
(19), and measures of segregation and disparities from work by the Kaiser Family 
foundation (20). 
 We obtained data on state characteristics from several sources. We extracted the 
geographical area, the number of counties, and the federal government expenditure per 
capita from the Census, and the number of cars in the population from an industry trade 
report (21). We determined whether states had “home rule” , defined as whether states 
were characterized by state control, local control, or by inference, mixed control, from 
the 2008 National Profile of Local Health Departments (22).  
 We estimated the total number of healthcare practitioners and the number of 
active physicians per thousand population (PTP), respectively, from the Bureau of Labor 
and Statistics (23) and the American Medical Association 2006 (24). We obtained data on 
the size of the medically underserved population and the percentage of the population 
who have not visited a doctor in the last year because of cost from State Health Facts 
(25). From the CDC’s Behavioral Risk Factor Surveillance System (BRFSS) (26), we 
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extracted the state specific population percentages associated with various health 
conditions.  
 We used several sources to quantify health-seeking behaviors and use of 
preventive services. We obtained state-specific influenza vaccination rates for previous 
seasons for different population groups from CDC’s BRFSS (27). We also considered the 
percent of adults with a dental visit in the past year (28), the percent of women who had a 
Pap smear in the past 3 years (25), and the percentage of adults aged 65+ who have ever 
had a pneumococcal vaccine (25). 
State-specific vaccination program and surveillance information  
 We obtained information on the emergency funding provided to states for the 
H1N1 pandemic from CDC reports (29): Total (Public Health Emergency Response 
(PHER) funds per capita in 2009; unobligated percentage for PHER I and II (awarded in 
July and August for assessment and planning, respectively) to determine the amount 
spent; and total or unobligated Phase III Public Health Emergency Response (PHER) 
funds per capita (30) (awarded in September 2009 for implementation of campaign).  
 Reports from the Outpatient Influenza-like Illness Network (ILINet) (31) obtained 
from the CDC, provided weekly values for the proportion of outpatient visits for 
influenza-like illness (ILI) at participating providers, by state, from which we calculated 
the week of peak prevalence in Fall 2009, and the length of time with major ILI activity 
by several different measures: Peak week for number of ILI cases after week 30; peak 
number of cases after week 30, per thousand population; percentage of weeks with % ILI 
above 2.3, after week 30; percentage of weeks with number of cases above 1/3 of the 
peak; number of weeks from peak until ILI dropped below 1/3 (or 1/2) of the peak. 
 We extracted information on state processes and decisions from a survey of 
immunization program managers conducted by the University of Michigan to provide 
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CDC with situational awareness during the H1N1 campaign (32). Findings from the 
survey were used to categorize states according to who approved providers (state or local 
public health), whether vaccine allocation to private providers was made at the state or 
local level, early allocation strategies during the shortage period (e.g., pro-rata, some per 
county, focused on target populations), whether or not vaccination had expanded beyond 
the ACIP target groups by Dec 4 (similarly, by Dec 18), use of retail vaccinators as of 
December 18 (widely, minimal, later or not planned), and whether or not (states, or local 
health departments, or third parties) distributed vaccine directly to providers (i.e., vaccine 
that was not shipped directly from the centralized distribution system).  
 We obtained information on the amount of vaccine allocated to each state over 
time, the maximum number of provider sites to which each state could have vaccine 
shipped through the centralized distribution system (“ship-to” sites) (3), the number of 
providers/practices that had entered into an agreement by 12/16/09 with their state health 
department to provide H1N1 vaccine (33), distribution center assignment (which of four) 
(3), the number of vaccine doses received in each state through the federal pharmacy 
vaccination initiative (34) in late 2009, and self-reported data from states on doses 
distributed to or administered in public settings (35), all from internal CDC reports.  
 Information on the date, address, and number of doses shipped to each location, 
from the beginning of the campaign through December 9, 2009 (which covers the major 
shortage period) was obtained from the centralized distribution shipping records (2). This 
allowed us to calculate the number of unique sites to which vaccine was shipped (ship-to-
sites), the number of shipments PTP, and the average number of shipments per site. We 
also calculated the lead-time from allocation to shipment (i.e., the average number of 
days between when a state received an allocation and ordered the vaccine, plus the 
average number of days doses spent between order placement and shipment), and the 
ordering frequency per week. Shipments during this time period were sent overnight to 
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their destination (regardless of distance), to arrive when receiving locations within the 
state were open. Lastly, we calculated the variation in doses PTP across counties within a 
state, by averaging the absolute value of the difference between the overall state doses 
PTP minus the doses PTP in each county. 
 We categorized shipments by the type of provider (e.g., pediatrics or children’s 
clinic, one of several kinds of specialists, local health departments) through a series of 
targeted queries based on name. From this derived data, we calculated proportion of 
shipments or doses PTP to providers focused on children, primary care, county health 
departments, unclassified medical doctors, internists, specialists, long-term care, veterans, 
urgent care, hospitals, clinics, pharmacies, jails, military, government, universities, and 
nursing homes; we also combined these in several subgroupings driven by like 
characteristics that might explain differences in coverage: general internists and 
specialists combined (internists and specialists can be grouped because both serve adults; 
however, while internists may provide primary care, adults may be less likely to visit 
internists or specialists during a short campaign); targeted access (doses sent to long term 
care, internists, specialists, nursing homes, and children); open sources and children 
(doses sent to counties, primary care, and children); all locations other than children or 
county; general access locations (primary care, MDs that could not be classified by 
specialization, counties, hospitals, urgent care, clinics, or pharmacies); and restricted 
access institutions (universities, military, jails, government, companies and veterans). 
Information was adequate to categorize more than 75% of the overall shipments. 
Appendix A provides a comprehensive list with variables considered, and their sources. 
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Analysis 
 The variable selection process continues to be a recurrent and difficult problem to 
deal with (36), and regression requires making decisions on variable selection approaches 
and other modeling perspectives (37).  We certainly avoided trying to consider every 
combination of every set of variables and pick the model with the highest R-squared (or 
best Akaike information criterion (AIC) value), which would pose a large combinatorial 
problem. Although we considered some automatic variable selection algorithms during 
the exploratory phase, we found them not effective for dealing with our highly correlated 
variable set. Thus overall, we used stepwise approaches, evaluating at each step both the 
explanatory power of additional variables (and their significance in the model) along with 
the correlations among variables. 
 Statistical theory indicates that it is relevant to cluster highly correlated variables 
and select at most one representative variable for each of these clusters to test into the 
regression model (see for example Doctoral Thesis work by S. Park (38)). Also, it has 
proven useful for the construction of models to select the regression variables while 
controlling for interrelationships among them (39). We followed these principles, and 
enforced them in our implementation in three ways: 1) by selecting initial sets of 
variables that were not highly correlated among them, but correlated with H1N1 
coverage, 2) by restricting the variables that had a high correlation with any other 
independent variable in the model from entering into the model, and 3) by allowing 
swaps of highly correlated variables.  Below we give a more detailed description of our 
process for obtaining a final model: 
1. We quantified the group of variables that were the most highly correlated (either 
positively or negatively) with adult coverage.  Examples of these include: 1) socio-
economic variables such as percentage of population who is black (variable c4) and 
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percent high school graduate or higher (c10); 2) health mortality or morbidity such as 
cardiovascular deaths (ah10), mortality with end-stage renal disease (ah43), adults with 
diabetes (ah2), good or better health reported (ah4); 3) use of health services such as 
previous flu vaccinations (e.g., sf2, sf3, and sf7) and percentage reporting not seeing a 
doctor because of cost (ah25); 4) H1N1 epidemiology, the  percentage of weeks with % 
ILI above 2.3 after week 30 (pw3); 5) H1N1 campaign, the average number of days 
between allocation and shipment of vaccine (o7).    
2. Many of these variables (e.g., socio-economic or mortality) had high correlations 
with each other or with many other potential variables. Some variables, such as percent of 
black population or education attainment had many collinearities, making it difficult to 
develop strong models from them. Therefore, variables with many collinearities were not 
chosen as starting points for the models. 
3. We chose one small initial set of variables at a time to begin model development 
(could be a single variable), where we selected from among categories or variables that 
were not too highly correlated with many other potential dependent variables, but still 
had a significant correlation with the independent H1N1 coverage variable. Examples of 
good starting variables were previous seasonal flu coverage variables. For each startup 
model, we added one variable at a time (stepwise forward selection, using the add1 
function in R), where we chose new variables with the highest potential to benefit the 
model from a set of potential variables while preventing the inclusion of any variable that 
was highly correlated with those already in the developing model.  With each new model, 
we checked for potential variables to remove by examining information such as p-values 
and measures of potential benefit to the model (reduction of AIC, using the drop1 
function in R).   We also considered swapping variables in a model by highly correlated 
potential variables if the latter consistently pointed to be of high potential benefit to the 
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model.  We iterated many times with steps forward and backward until arriving at a 
model without obvious improvements. 
4. We began the model development process again, by starting with a new set of 
initial variables, iterated, until arriving at another model without obvious improvements.  
Models with higher adjusted R-squared were kept and models with lower adjusted R-
squared were discarded. 
5. Although it would be virtually impossible to analyze all possible combinations of 
the variables, we observed after a few repetitions that some variables would consistently 
find their way into the models, and actually appeared in our final model, sometimes even 
without having some of the highest individual correlations to H1N1 coverage. 
Results 
 Seven variables including lead-time from allocation to ordering and shipment, the 
maximum number of ship-to sites per thousand population, past seasonal influenza 
coverage for non-high risk adults age 18 -- 49, percentage of doses categorized as sent to 
internists and specialists, percentage of women 18 and older with a pap smear in the last 
three years, percentage of weeks with ILI above 2.3 after week 30, and the percentage of 
residents of Hispanic or Latino origin were significant for predicting vaccination 
coverage in adults (Table 2.1). The best model found explained the variation in state-
specific adult vaccination coverage with an adjusted R-squared of 0.76 and a p-value 
close to 0 (Table 2.2).  
 For supply decisions, a long lead-time was associated with lower coverage, and 
the associated coefficient has a relatively large magnitude. Additional analysis of lead-
time indicated that a state’s relative lag tended to be consistent throughout the months 
considered. We also found that lead-time is correlated with some variables related to 
shipment choice (e.g., positively with use of third parties for distribution, and negatively 
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with shipments per ship-to site). The vaccine allocated to internists and specialists as a 
percentage of the total shipped was negatively associated with coverage, and having a 
large number of maximum ship-to sites was positively associated with coverage. 
 
 
Table 2.1: List of variables in the final model, including the dependent variable at the top. 
Table shows the variable’s name, description (with reference for the data), average value, 
standard deviation, and maximum and minimum values. 
 




Dependent Coverage on persons aged ≥ 
18 yrs. 
MMWR(7) 19.9 5.3 34.4 8.7 
Indep1 Percent of Women Age 18 
and Older Who Report 
Having Had a Pap Smear 




82.7 2.9 88.9 74.1 
Indep2 Resident population: Hispanic 
or Latino Origin, percent 
(July 1 2009 - estimate) 
Census(17) 9.8 9.6 44.9 1.1 
Indep3 Average days from allocation 




6.3 2.3 12.5 2.1 
Indep4 Percentage of weeks with % 
ILI above 2.3, after week 30 
Report CDC(31) 42 24.4 97.4 10.3 
Indep5 Seasonal influenza Coverage 
for non-high risk adults 18 -- 





22.6 5.1 37.8 11.9 
Indep6 Maximum number of ship-to 




0.5 0.1 0.74 0.00* 
Indep7 Percentage of doses 
categorized as sent to 
internists or specialists** 
Report CDC 
(Calculation) (2)  









Table 2.2: Regression results for predicting the state level vaccination coverage for the 
adult population. The table contains the variable name, short description, point estimation 
of the variable’s coefficient, coefficient‘s standard error, coefficient’s t-value, and results 
of the significance test. 
 
Variable Short Description Estimate Std. Error t value Pr(>|t|)  
 (Intercept) 2.66E-16 0.06807 <0.001 1.00E+00  
Indep2 % Hispanic 0.378 0.07953 4.753 <0.001 *** 
Indep5 Past influenza 
Coverage 
0.3599 0.07928 4.54 <0.001 *** 
Indep1 % Women w/ Pap 0.3002 0.07653 3.923 <0.001 *** 
Indep6 Max # Sites 0.1807 0.07061 2.558 0.01412 * 
Indep7 % to Specialists -0.295 0.07788 -3.788 <0.001 *** 
Indep4 % weeks ILI high -0.4366 0.07362 -5.931 <0.001 *** 
Indep3 Lead-time -0.4419 0.07401 -5.97 <0.001 *** 
Significance codes: 0 < ‘***’ < 0.001 < ‘**’ < 0.01 < ‘*’ <0.05 




Vaccination coverage was positively associated with past influenza vaccination 
coverage; while we found a strong association, there were several other effects that were 
also large in magnitude. Coverage was also positively associated with the percentage of 
women with a pap smear, and the percent of the population that is Hispanic. A long 
duration of ILI severity peaks (defined by the percentage of weeks in the Fall with 
percent ILI more than 2.3) was negatively associated with coverage. To provide more 
information on our modeling, a supplementary table in Appendix B presents examples of 
other variables highly correlated with those factors in our final model. 
Discussion 
In an effort to identify lessons learned for a future pandemic vaccination event, 
we sought to identify factors related to vaccination program decisions and processes that 
may have facilitated or hindered vaccine uptake. Program factors that were associated 
with vaccine uptake included the lead-time between allocation and ordering and shipping, 
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and the type of providers receiving vaccine. Factors not related to program decisions such 
as health-seeking behaviors and population characteristics also contributed to predicting 
state-to-state variation, as would be expected given baseline variation in previous 
influenza vaccination coverage(27) and other findings (40-42). 
Lead-time from allocation to ordering and shipment was negatively associated 
with vaccination coverage. Steps in the ordering process varied by state and could include 
requesting specific orders from providers (in advance of allocation or after receiving an 
allocation), decisions on where to distribute vaccine, and notification of decisions. States 
also determined the frequency of ordering, the day(s) of the week to order, the number of 
providers participating or receiving vaccine, and the overall process to follow, all of 
which could affect the lead-time. Because of the initial focus on ACIP-defined target 
groups, in many states adults without high risk conditions were not eligible for 
vaccination until demand for vaccine had already begun to wane. Delays in allocated 
vaccine being made available to the population could have resulted in less vaccination. 
On the other hand, lags in ordering could be a consequence of decreasing demand, and 
thus be a result of lower vaccination rates rather than a cause. The tendency for lags in 
ordering to be consistent for a given state throughout the time period studied, suggests the 
lead-time resulted from the ordering process.  
We also found a relationship with the type of providers or locations to which 
vaccine was directed. For adults, vaccine sent to providers with specialized services or 
patient base was associated with lower coverage. This could be because not all adults 
visit internists or specialists frequently enough to be vaccinated in this time period; it 
could also be that those providers had less focus traditionally on vaccinating so patients 
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looked elsewhere for vaccine. Overall, only a small proportion of vaccine was sent to 
internists and specialists. 
One variable may be more a measure of health infrastructure than the supply 
chain system itself.  In particular, the maximum number of sites to which vaccine could 
be directly shipped through the centralized distribution system) was positively associated 
with vaccination coverage. (In constrast, another variable measured the actual ship-to 
sites registered or used within a state.)  The maximum number of ship-to-sites allowed 
for each state was based on a formula that included the population size as well as the 
number of existing VFC providers. A high number of VFC sites per capita could be a 
reflection of a more robust infrastructure for providing vaccine. 
State factors unrelated to supply chain decisions about H1N1 vaccine were also 
related to coverage, specifically included usage of health services. Others have found that 
for an individual, past influenza vaccination is a strong predictor of annual influenza 
vaccination (8, 13): a relationship that may reflect both differences in infrastructure and 
differences in attitudes. The finding in this paper demonstrates that pandemic influenza 
vaccination also is associated with uptake of seasonal vaccine. The association between 
coverage rates and rates of receipt of Pap smear may be a reflection of utilization of 
preventive care, although no further analysis could be carried out to determine if this 
effect was present only among women.  
Some characteristics of the epidemic may have also influenced coverage. For 
states where the epidemic lasted longer, coverage was lower. This could be because 
vaccine was made available to non-high risk adults later in the season, and persons may 
have reasoned that they had likely been exposed to the disease already and did not need 
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vaccination. Conversely, the positive association between coverage and the percentage of 
Hispanics may reflect higher vaccination rates in communities with greater perceived risk 
(43) due to the virus emerging from Mexico. In general, Hispanic populations did not 
have a higher coverage than the overall average. (44) 
This study had several limitations. First, cross sectional studies and regressions 
are useful for identifying associations, but they have a number of intrinsic limitations, for 
example, we cannot determine causality, and for complex cases like the one analyzed 
other good regression models may also exist for the same set of variables. Secondly, the 
ecological approach followed does not point to individual characteristics of the 
population but to state-level conditions, and does not analyze potential variations within 
states. Third, the data from the centralized distribution system covers shipments through 
December 9, 2009, and the outcome measure is vaccination coverage as of the end of 
January 2010. The gap may not be as large as it seems, since coverage for adults 
increased from 17.3% (adults ≥19 (45)) at the end of December 2009 to around 18.2% 
(adults ≥18, derived from state-specific rates (7) and adult populations (17)) at the end of 
January 2010. Additionally, the number of people vaccinated by the end of January 
(74M) is approximately the same as the total vaccines shipped by December 9 (72M) 
though this comparison does not take into account receipt of second doses by children. 
Fourth, the vaccine shipment data represented shipment location, which is not necessarily 
the same as the final place of administration of vaccine (e.g., vaccine may have been 
distributed from a third party distributors or local health department to providers). As a 
result, the number of locations of administration may be underestimated, or the provider 
type may be misclassified. Fifth, some shipping data were missing or potentially 
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inaccurate. Provider type could not be determined for 25% of shipments, the information 
on state and local decisions and processes was not always complete, and databases could 
have errors. Finally, the number of dependent variable observations is fairly small (51), 
and many factors may potentially be associated with H1N1 coverage.  
 The distribution and administration of the H1N1 vaccine was a test of the health 
emergency response systems, and it is an opportunity to identify specific approaches that 
may result in higher vaccine uptake in a future event of this nature. Several of the 
findings warrant further consideration. The findings suggest that continued efforts to 
increase uptake of influenza vaccination may result in increased uptake in an emergency 
response. The negative association between order lags and coverage is an important 
aspect of the supply chain and distribution. It is possible that time lags are a function of 
the system design or processes, which would suggest monitoring and/or designing the 
system for fast response within the states in an emergency is needed. There can be many 
decisions made at the state level that can affect lead-time including ordering frequency, 
number of delivery locations, on which days orders were placed, use of third parties, etc. 
Further study would be useful in this area. Our results on type of location to which 
vaccine was directed may provide some guidance on increasing coverage, e.g., in a 
campaign with limited resources and time pressures, sending to general access or public 
locations may be beneficial. As more adult and specialty providers, including pharmacies, 
take on the role as vaccinators, this strategy may change. This, too, remains an area 
where additional analysis is useful, such as collecting information on shipments by type 
of provider, examining the small number of states where registry information records the 
location of vaccine administration, or additional analysis on where vaccination occurred 




SUPPLY CHAIN AND SYSTEM FACTORS TO EXPLAIN H1N1 
STATE VACCINATION RATES FOR CHILDREN AND HIGH-RISK 
ADULTS IN US EMERGENCY RESPONSE TO PANDEMIC 
 
Introduction 
 A national vaccination campaign was rolled out in the fall of 2009 in response to 
the H1N1 influenza pandemic. Initially, the vaccine was in short supply, in some areas 
until early December. The vaccine was purchased by the federal government and 
allocated to states as it became available, in proportion to population size. The flow of 
doses from the manufacturers to the national distribution centers and then to final points 
of distribution built on an existing contract for management and distribution of vaccines 
in the Vaccine for Children (VFC) program. Depending on their internal structures, states 
or local authorities decided how to distribute vaccine within their jurisdiction. 
CDC’s Advisory Committee on Immunization Practices (ACIP) issued 
recommendations for the use of the vaccine (46). The initial target groups were: pregnant 
women, household contacts or caregivers for infants aged <6 months (e.g., parents, 
siblings, and daycare providers), personnel who have direct contact with patients or 
infectious material at health-care and emergency medical services, all people between 6 
months and 24 years of age, and persons 25 through 64 years old with health conditions 
associated with higher risks of complications if infected (to whom we will refer as “high-
risk adults”) (46). The recommendations further specified priority groups in the event of a 
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vaccine shortage, giving priority to the first three of the previous groups, and in addition 
children aged 6 months—4 years, and children and adolescents aged 5—18 years who 
have a medical condition that could cause them influenza-related complications. Finally, 
the ACIP recommendations stated that decisions about opening vaccination up beyond 




Figure 3.1: 2009 pandemic H1N1 vaccination coverage by state for 3 different 




Despite the pro-rata allocation of vaccine to the states, by the end of January 2010 

































































































































































































































































































































Source: MMWR 2010;59(12):363-8 [2] 






aged 6 months to 17 years ranging from 21.3% to 84.7%, and for high-risk adults from 
10.4% to 47.2%. This variation suggests that implementation strategies (e.g. location of 
vaccination or types of providers receiving vaccine) may have affected state-level 
vaccination rates achieved and that specific distribution strategies may be associated with 
reaching specific groups. Figure 3.1 summarizes coverage outcomes (7) for children and 
high-risk adults compared to overall adults (18 and up, including those with high-risk 
conditions). Coverage rates were higher for more than one group in some states, pointing 
to the potential contribution of state systems, processes, or underlying characteristics to 
coverage achieved. 
 
Figure 3.2: Example supply chain for H1N1 vaccine during the 2009-2010 pandemic 




























In a previous study, we found that certain supply chain and system factors were 
associated with state-level coverage of overall adults (47). The purpose of this study was 
to extend that analysis and focus on factors associated with coverage of children and 
high-risk adults, two of the initial target groups for vaccination. Some of the 
characteristics of the state’s health supply chain that we expected to relate with coverage 
of children and high-risk adults were the number of locations where vaccine was 
available, type of providers that received doses, focus on school vaccination, timing of 
opening of vaccine distribution to non-priority groups, use of third parties for transfer and 
redistribution of vaccine, and use of retail and pharmacy for vaccination. Figure 3.2 
represents an example of the construction of the supply chain of vaccine. We considered 
health infrastructure characteristics for the states, and data about vaccine shipments and 
distribution strategies during the primary shortage period. To account for other factors 
that may affect vaccination coverage (40, 42, 48-51), we included factors pertaining to 
the underlying characteristics of the state’s population such as demographics and 
utilization of preventive health services. 
Methods 
Design 
 We used linear regression models to perform an ecological analysis on the 
relationship between state-level 2009 H1N1 vaccination rates in children 6 months to 17 
years of age, and high-risk adults 25-64 years old, and variables describing 1) the state’s 
supply chain and process design for the vaccination campaign, and 2) general population 
and health characteristics of the states. 
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Data 
 We separately analyzed two outcomes, both related to the state-specific 2009 
H1N1 vaccination coverage: (i) the estimation of children’s vaccination rate as a 
percentage (0% – 100%) of the population, and (ii) the estimation for the percentage of 
high-risk adults vaccinated, both of them calculated by the CDC(7, 52). 
Population and state characteristics 
 The data sources for the analysis were varied including census(17, 18), income 
inequalities(53), measures of segregation and disparities(54), industry trade reports on 
number of cars(21), the 2008 National Profile of Local Health Departments(22), the 
Bureau of Labor and Statistics(23), the American Medical Association 2006(24), State 
Health Facts(25), CDC’s Behavior Risk Factor Surveillance System (BRFSS)(26), and 
CDC estimates on influenza coverage for previous seasons(55)). The details on this data 
(and all others) are explained Appendix A.  
 For the analysis of children, we additionally considered several variables from the 
National Survey of Children’s Health 2007 (56) that describe the children’s general 
health condition, the prevalence of chronic health conditions among them, their private or 
public health insurance coverage, if they have preventive visits to the doctor in the past 
12 months, and if their home meets the medical home criteria. 
To calculate the state-specific 2009 H1N1 estimation for the percentage of high-risk 
adults vaccinated, participants on BRFSS and NHFS surveys administered during 
November 2009-February 2010 were asked if they (or their children) had received an 
H1N1 vaccine during October 2009-January 2010. High-risk conditions in the surveys 
include anemia (including sickle cell), asthma, diabetes, coronary heart disease, kidney 
problems, lung problems other than asthma, myocardial infarction, and a weakened 
immune system caused by illness or medicines (7, 52). 
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State-specific vaccination program and surveillance information  
The analysis included information on emergency response funds provided to 
states(29, 30); reports from the Outpatient Influenza-like Illness Network (ILINet)(31); 
information on the amount of vaccine allocated to each state over time; detailed vaccine 
shipping information including date, address, and number of doses shipped to each 
location, from the beginning of the campaign through December 9, 2009(2) (which 
covers the major shortage period); the maximum number of provider sites to which 
vaccine could be shipped through the centralized distribution system; the number of 
vaccine doses received in each state through the federal pharmacy vaccination 
initiative(34, 57) in late 2009; and self-reported data from states on doses distributed to or 
administered in public settings(35). 
Information on state processes and decisions from surveys during the 
campaign(32) contained several variables that we considered including: the percentage of 
VFC providers who participated in the H1N1 campaign; whether or not vaccination had 
expanded beyond the ACIP target groups by December 4, 2009 (similarly, by December 
18); whether school clinics had been held by October 27 (or doses were being held for, or 
waiting to hold clinics at schools) and whether school vaccination was a main focus; and 
if 3
rd
 party distribution was used to transfer or redistribute to small providers. When 
analyzing data from the Simultaneous Tracking Project led by Clark (32), we did not 
include in the analysis those variables that had a considerable number of missing data 
points, given that missingness can deeply affect the adequacy of out models. 
From the detailed shipping information we calculated the average number of 
shipments per location (the total number of shipments divided by the total number of 
ship-to-sites per state). Performing targeted queries, we also categorized shipments by 
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type of provider, showing that vaccine went to pediatricians or children’s clinics, primary 
care facilities, county health departments, internists, specialists (not including specialists 
for children or women), long-term care, veterans, urgent care, hospitals, clinics, 
pharmacies, and other venues that could be more closely related to the vaccination of 
children and high-risk adults. We also combined some of these categories in 
subgroupings to see which had a greater impact on these populations. For example: the 
targeted access group included doses sent to long term care facilities, internists, 
specialists, nursing homes, and children; the general access group include doses sent to 
primary care, MDs, counties, hospitals, urgent care, clinics, or pharmacies. Information 
was adequate to categorize more than 75% of the overall shipments. 
Analysis 
We constructed separate models for children (6 months to 17 years) and high-risk adults 
(25 to 64 year olds with a chronic condition) because we expected factors affecting 
coverage to differ across groups, and to differ from factors associated with vaccination 
rates in overall adults (18 and up, including those with high-risk conditions (47)). 
The primary technique used for modeling was multivariate linear regression 
(ordinary least squares).We used a logarithmic transformation of the vaccination rate for 
children, to better approximate normality. We calculated simple descriptive statistics for 
all the analyzed outcomes and factors (means, standard deviations, and proportions). 
Outliers were not removed for the analysis. Data was linearly scaled to values in [0, 1] 
before performing regressions. 
We selected a number of potential initial predictors for each of the dependent 
variables based on their correlation with the outcomes. From these initial models we 
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developed models by stepwise addition, elimination, or by interchange of factors. At each 
stage, we chose variables to include or remove based on their statistical significance and 
their potential to explain variability, while we examined correlations to avoid high 
collinearities in the model. Models were evaluated on adjusted R-square values and the F-
statistic, with individual variables significant at p-value<0.05. The regressions were 
performed with R statistical software package version 2.11.1(58). Some descriptive 
statistics were calculated in Microsoft Excel versions 11 and 12. 
Coverage of 2009 H1N1 vaccination was measured as the percentage (0%-100%) 
of population who reported having been vaccinated. The outcome for high-risk adults 
was used as the dependent variable for the linear regression model built for that sub-
group. The outcome for children was first transformed by calculating the natural 
logarithm of the coverage percentages. For example, a 30% coverage for the high-risk 
population, would have been assigned the value 30 for modeling, while a 30% coverage 
in the children model was transformed to ln(30) = 3.401 for modeling.  
To favor computational stability, all variables, both dependent and independent, 
were linearly scaled to values between 0 and 1, before calculating the coefficients of the 
regression model. The minimum value of each of the variables was set to 0, while the 
maximum value was set to 1. All other values were scaled accordingly. For example, the 
coverage for high risk adults ranged from 10.4% to 47.2%. We will refer to the difference 
between the maximum and the minimum values in a variable as the range of the variable, 
in this case: 47.2 – 10.4 = 36.8 is the range of the high-risk adult’s coverage. Then, when 
scaling, 10.4 becomes 0, and 47.2 becomes 1, and all other points in this variable take 
values according to their difference with the minimum value in proportion to the range. 
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In this case, a coverage of 30% would become after scaling: (30 – 10.4)/(47.2 – 10.4) = 
0.53. Following the same example, the values for the coverage in children ranged from 
21.3% to 84.7% before the logarithmic transformation. Then, the transformed values 
range from ln(21.3) to ln(84.7). This is, from 3.059 to 4.439. Scaling these values 
between 0 and 1, the minimum 3.059 becomes 0, while the maximum 4.439 becomes 1. 
In this case, a coverage of 30% for children would be transformed to ln(30) = 3.401, and 
this value would become (3.401 – 3.059)/(4.439 – 3.059) = 0.248 in a 0-1 scale. 
Since all of the variables were scaled between 0 and 1 before calculating the 
linear regression coefficients, each of the coefficients represents a proportion between the 
expected change (in terms of the range) of the dependent variable and a change (in terms 
of the range) of its independent variable, given that all other variables remain unchanged. 
Since the values of the high-risk model were only scaled (and not transformed), this 
interpretation extends directly to the un-scaled (real) values. As an example, the 
coefficient for the previous seasonal influenza coverage has a value of 0.36, and the 
seasonal influenza variable has a range of 43.9 (55.4 maximum minus 11.5 minimum). 
According to our model, if a state would increase its seasonal influenza coverage by 10% 
of the range for this variable (a percent change of 4.39% in the proportion of people 
vaccinated for seasonal influenza) it would expect to increase by 0.36*0.1*(range of 
dependent variable), which equals 0.36*0.1*36.8 = 1.32% the high-risk adult 2009 
H1N1vaccination coverage, if all other variables remain unchanged. Notice that we can 
address the effect of a change without necessarily considering the initial value for the 
variables. This is possible due to the linearity of the model. 
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For the children’s model, the logarithmic transformation requires a more careful 
interpretation. The dependent variable of the regression model is the logarithmic 
transformation of the real dependent variable, the 2009 H1N1 vaccination coverage for 
children. Given that the transformation is logarithmic and not linear, we need to consider 
the value of the dependent and the independent variables, as well as the change, to 
estimate the new value of the true dependent variable. For example, the coefficient for the 
% of children population is -0.18817. The range of this variable is 22.1, and the range of 
the logarithmic transformation of coverage is 1.38. Suppose that a certain state had an 
H1N1 coverage of 30% for children, with a 10% of its population younger than 18 years. 
In this example, an assumed increment of 2.21% in the proportion of children population 
(10% of its range) would cause a decrease of 1.88% of the range of H1N1 coverage for 
children in that state, if all other variables remain unchanged. The transformation of the 
30% coverage is ln(30) = 3.401, and the size of the change in this transformed variable is 
-0.0188*1.38 = -0.026. Therefore, the final value of the transformed variable is 3.401 – 
0.026 = 3.375. The real value of the coverage will be exp(3.375) = 29.2%, representing a 
real change in H1N1 coverage of only 0.8%. 
One of the main assumptions to achieve optimality of the coefficients’ estimation 
in linear regression is that the distribution of the dependent variable, conditional on the 
independent variables, is normal. In other words, the error term of the regression model is 
assumed normal. This assumption does not imply normality of the independent variables, 
which is not required for linear regression. Additionally, since normality of the 
conditional distribution of the dependent variable is rarely found, approximation to 
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normality is usually accepted, understanding that such approximation will provide good 
coefficient estimators, but likely not optimal (59). 
Results 
Nine independent variables were significantly associated with vaccination 
coverage in children and eight for high-risk adults (fifteen different independent variables 
in total, two of which are shared by both models). A list of these variables can be found 
in Table 3.1. The adjusted R-squared for the regression models is 0.82 for children (Table 
3.2) and 0.78 for high-risk adults (Table 3.3), and both of their p-values are close to 0.  
 
 
Table 3.1: List of variables appearing in either model, including the dependent variables 
at the top. Table shows the variable’s name, description, reference for the data, average 
(Avg), standard. 
 
Variable Description of Variables Reference Avg S.D. Max Min 
D-1 
Coverage of Children 6 months 
to 17 years 
MMWR(7) 38.9 11.9 84.7 21.3 
D-2 
Coverage of persons aged 25--
64 years at high-risk 
MMWR(7) 25.4 7.6 47.2 10.4 
I-1 
Percent of Women Age 18 and 
Older Who Report Having Had 
a Pap Smear Within the Last 
Three Years, 2008 
State Health 
Facts(25) 
82.7 2.9 88.9 74.1 
I-2 
Maximum number of 
vaccination sites per state per 
thousand population (2009) 
CDC Report 
(Calculation) (3) 
0.5 0.1 0.7 0.00* 
I-3 
Percentage Reporting Not 
Seeing a Doctor in the Past 12 
Months Because of Cost 
State Health 
Facts(25) 
13 3.4 20.5 6.2 
I-4 
Underserved Population Living 
in Primary Care Health 
Professional Shortage Areas, 
as of September, 2008 
State Health 
Facts(25) 
12.6 7.6 34.4 1.7 
I-5 
Resident population under 18 
years, percent (July 1 - 
estimate) 2008 




Table 3.1 (continued) 
Variable Description of Variables Reference Avg S.D. Max Min 
I-6 
Resident population: American 
Indian and Alaska Native 
alone, percent (July 1 - 
estimate) 2008 
Census(17) 1.8 2.9 15.3 0.2 
I-7 
Total Public Doses Oct-Feb 
divided by Estimated People 
Vaccinated 
CDC Report(35) 39.6 20.3 98.9 11.9 
I-8 
H1N1 Vaccine Doses 
Distributed or Administered to 
Date from Large Pharmacy 
Chains / Retail-Based Clinics 
to States as of January 29, 
2010 
CDC Report(34) 10 6.6 30.1 0 
I-9 
Seasonal influenza Coverage 





55.4 11.5 80.5 27.3 
I-10 
Natural logarithm of the ratio 
of number of shipments to 
number of ship-to-sites 
CDC Report(2) 
(Calculation) 
4 3 19.6 1.6 
I-11 
Percentage of doses sent to 
primary care, MDs, counties, 




66.4 20.1 99.4 4.7 
I-12 
Total number of cars, trucks 




0.81 0.16 1.19 0.36 
I-13 
Coverage expanded to general 
population by Dec. 4, 2009: 1- 




0.42 0.49 1 0 
I-14 
School-based clinic strategy: 1- 




0.3 0.46 1 0 
I-15 
Third parties make 





0.16 0.37 1 0 
 
For children, four factors related with supply chain and campaign processes 
contributed positively to coverage: average ratio of the number of shipments per ship-to-
sites, the state focus on school vaccination, the use of third parties (i.e. state or locally 
hired distributors) for further distribution to small providers, and the estimated proportion 
of doses that were administered in public sites.  
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Table 3.2. Regression results for predicting the state level vaccination coverage for 
children 6 months – 17 years, United States, end of January 2013. 
 
Coefficients when predicting ln(children coverage percentage) 




 (Intercept) 0.01488 0.05956 0.25 0.804 
Indep15 (Re)Shipments 0.42308 0.07285 5.807 0.000 
Indep19 Focus on School 0.36769 0.07239 5.079 0.000 
Indep6 Max # Sites 0.29734 0.07016 4.238 0.000 
Indep20 3rd Party Dist'n 0.24461 0.06349 3.852 0.000 
Indep12 % Public Doses 0.2125 0.06837 3.108 0.003 
Indep10 % Children 
-
0.18817 
0.07965 -2.362 0.023 






0.07701 -3.765 0.001 
Indep8 % Visit, Cost 
-
0.35139 
0.08217 -4.276 0.000 
 
 
Two factors were related to existing health infrastructure: the maximum number 
of ship-to-sites had a positive association with coverage, and the percentage of medically 
underserved population (proportion of population living in primary care health 
professional shortage areas (25)) a negative association. Coverage was also negatively 
associated with population factors including the percentage of the population that will not 
visit a medical doctor because of cost, the number of vehicles per capita, and the 






Table 3.3: Regression results for predicting the state level vaccination coverage for the 
high-risk adult population, United States, End of January 2010. 
 
Coefficients when predicting coverage of high-risk adults 
Variable Short 
Description 
Estimate Std. Error t value Pr(>|t|) 
 (Intercept) -0.46318 0.09916 -4.671 3.51E-05 
Indep1 Women with Pap 
Smear 
1.44641 0.38477 3.759 0.000559 
Indep6 Max # Sites 0.54139 0.09705 5.579 1.99E-06 
Indep16 % Doses shipped 
to “general 
access locations”  




coverage adults  
0.3603 0.08525 4.226 0.000138 
Indep11 Pop. American 
Indian  
0.20897 0.0777 2.69 0.010474 
Indep13 Pharmacy and 
Retail  
0.17915 0.05251 3.412 0.001515 
Indep18 Expanded by 
Dec. 4th  
-0.11829 0.02398 -4.933 1.55E-05 
Indep9 % Underserved 
population  
-0.37442 0.06081 -6.157 3.14E-07 
 
 
For high-risk adults, two supply chain processes were positively associated with 
uptake: the percentage of doses shipped to “general public” locations, and the use of 
pharmacy and retail locations for vaccination; and one, the expansion of vaccination to 
the general public by December 4th, was negatively associated. Coverage was positively 
associated with population and health related factors: percentage of women with a Pap 
smear, past seasonal influenza vaccination, and percentage of population that is American 
Indian. Two infrastructure factors were associated: the proportion of the population 
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medically underserved (negatively) and the maximum number of ship-to-sites 
(positively).  
Figure 3.3A presents the Q-Q plot for the residuals of the children’s model, and 
Figure 3.3B the Q-Q plot for the residuals of the high-risk adults’ model. The closer the 




Figures 3.3A and 3.3B show Q-Q plots for the residuals of the children’s and high-risk 




We sought to identify factors related to vaccination program decisions and 
processes that may have facilitated or hindered vaccine uptake for two target groups for 
vaccination: children and high-risk adults. Several supply chain and system factors were 
associated with vaccination coverage of children and of high risk adults.  With the 
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exception of the maximum number of ship-to sites, a factor that was also associated with 
overall adult coverage [3], factors associated with coverage of children and of high risk 
adults did not overlap.  Additionally, factors not related to program decisions such as 
health-seeking behaviors and population characteristics were also associated with state-
to-state variation, as would be expected given baseline variation in vaccination coverage 
for recommended vaccines(25) and the variety of factors associated with vaccinations, 
both for high-risk individuals(48, 50, 51, 60) and children(40, 42).  
Several findings were related to the type of providers or locations to which 
vaccine was directed. For children, having a focus on school vaccination was associated 
with higher coverage (five of the six states that achieved the highest coverage in children 
implemented statewide school vaccination programs(7, 32)), as was distribution to public 
sites. Public sites can include schools, but also locations such as mass clinics run by 
health departments. For high-risk adults, more distribution to providers with a broad base 
of access (including pharmacies, primary care providers, county health departments, etc.) 
was associated with higher coverage. It is noteworthy that coverage for overall adults was 
negatively associated with distribution to internists or specialists [3]. Taken together, the 
results for adults suggest that vaccine that was broadly accessible may have facilitated 
higher coverage. This could be because high-risk adults may not visit internists or 
specialists frequently enough to be vaccinated in this time period; that specialists 
traditionally have had less focus on vaccinating so patients may have looked elsewhere 
for vaccine, or that the cost in some settings was lower. For high-risk adults, the percent 
medically underserved is also negatively associated with coverage, which may also help 
explain the positive impact of open access locations and pharmacies.  
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The number of shipments per ship-to site was positively associated with coverage 
for children but not for high-risk adults. For children, this may reflect repeated shipments 
to locations such as local health departments, mass clinics, or pediatricians who may have 
offered repeated clinics. Some health departments monitored usage and distributed more 
vaccine to providers who were depleting vaccine supply faster, which is another potential 
hypothesis. The maximum number of sites to which vaccine could be directly shipped 
through the centralized distribution system was positively associated with vaccination 
coverage for both children and high-risk adults, a finding also observed for overall adults 
[3]. Because the number of ship-to-sites allowed for each state was based on a formula 
that included the population size as well as the number of existing VFC providers, this 
measure may reflect a more robust healthcare infrastructure. 
The expansion of vaccine availability to the general public by December 4th was 
associated with lower coverage for high risk adults. Early expansion could have resulted 
in less access for high-risk adults, especially if a state had sequential priorities (e.g., 
children first, then high-risk adults). However, because in most states, decisions about 
when to make vaccine available beyond the initial target groups were based on perceived 
demand for vaccine, e.g., as ascertained from provider vaccine orders and attendance at 
public clinics, so the decision to expand early could reflect lower demand in those states. 
Coverage for high risk adults was positively associated with uptake of seasonal 
vaccine for high-risk adults in 2007-2008, as it was for adults overall (47). This could be 
because the administration sites for adults were similar to past seasonal influenza 
campaigns or it could reflect use of preventative services. In contrast, the lack of 
association for children could reflect the fact that vaccine administration sites differed 
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from past seasons with school vaccination playing an unprecedented role during this 
influenza vaccination campaign. A second hypothesis for children is that the increased 
focus on them as a priority group served to motivate their vaccination by caregivers or 
providers.  The association between coverage rates in high-risk adults and rates of receipt 
of Pap smear may be a reflection of utilization of preventive care in a state, and could 
also reflect vaccination by Ob-Gyns (61). 
For children, lower coverage was associated with a higher percent of the 
population reporting they would not visit a medical provider because of cost; and 
coverage was positively associated with the proportion of vaccine being directed to 
public sites. These findings may relate to the relationship between cost and access (e.g., a 
mass clinic may have been free to patients, while visiting a specialty physician may result 
in a fee), as we found for high-risk adults. It is noteworthy that for both children and 
high-risk adults, the percent uninsured was highly correlated with coverage (though it did 
not add to the model). 
The negative association between coverage for children and the percentage of the 
population under 18 could be a combination of the pro-rata allocation and prioritization 
policies. Given the initial focus on vaccinating children, the amount of vaccine available 
per child was less in states with proportionately more children. Additionally, the vaccine 
available per child decreased since a second dose was recommended for children 6 
months through 9 years of age(62). In the event of a vaccine shortage, deviating from an 
overall pro-rata allocation may be justifiable, if a sub-population at higher risk is easy to 
identify, and the impact of increased allocation to this sub-population is potentially large. 
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This warrants further examination given the complexity of recommendations with 
multiple target groups. 
The use of third party distribution and number of cars per capita appeared in the 
model for children. Both have small individual correlations with the dependent variable, 
so they improve the overall model fit when controlling for other variables. 
This study had several limitations. As explained more fully in the article by 
Davila-Payan et al.(63) the shipment data ends December 9 2009, but we examine 
vaccination coverage at the end of January 2010. We also do not know where the vaccine 
was actually administered; this means for example, that we do not know whether repeated 
shipments to the same location, i.e., a local health department, were being distributed 
through mass clinics, schools, or other local providers. We were only able to determine 
provider type for 75% of shipments, and the information on state and local decisions and 
processes was not always complete. Modeling limitations include the fact that ecological 
approaches do not point to individual characteristics of the population but to state-level 
conditions, leaving out potentially relevant variations within states, and that that cross-
sectional studies cannot determine causality. Also related to the latter, it should be noted 
that there are multiple potential explanations for findings. While we aimed to include the 
most likely ones, the potential for bias should be recognized.  Additionally, we are 
identifying associations with a relatively small number of dependent variables (51), 
across many independent variables that have correlations, and confidence intervals of the 
coverage estimations were not considered in the regression. We have kept the best 
models we found, however, other good models could also exist. The supplementary table 
in Appendix C presents a summary of variables highly correlated with those in the 
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children and high-risk models. Our models provide a solid approach on the analysis of 
factors related with coverage. However, care should be taken in relying too heavily on 
any particular variable or finding without considering its interaction with other variables 
in the model.  
The distribution and administration of the H1N1 vaccine provided an opportunity 
to understand how specific approaches may affect vaccine uptake in priority populations 
in an emergency situation. Results from this analysis complement those examining 
factors associated with vaccination of overall adults and suggests that supply chain 
factors may affect vaccine uptake. The analysis also points to opportunities for future 
research such as further analysis on uptake and the relationship with spatial access to 
vaccine or access by provider type, and the role of urban or rural differences in vaccine 
uptake. These research questions and others can be informed by more detailed mapping 
of the process and system to show details of demand (e.g., by population or providers), 
supply (e.g. details on allocations and shipments including the final point of distribution 
and the category of provider), lead-times across the system, variations within and across 
states, where vaccine was administered, when, by who and to what subpopulation. Such 
data would also allow for a robust comparison of potential distribution systems and 




ESTIMATING CHILDHOOD HIGH-BMI BASELINE PREVALENCE 
IN SMALL GEOGRAPHIC AREAS 
 
Introduction 
Obesity is one of the most urgent health challenges considered by the Centers for 
Disease Control and Prevention (CDC) to impact health indicators in the US, and was 
included on their recently released list of “winnable battles”(64). Studies show that 
childhood obesity in the US remains at its highest point in history (65), with an 
approximately 16.9% prevalence in the 2–19 years old US population in 2010.  
Overweight (at or above 85% and below 95%) and obesity (at or above 95% of 
the BMI-for-age growth charts) (66, 67) in children pose both present and future health 
risks (68), making this population a target for interventions aiming to improve health of 
the overall population or children specifically.  Interventions can include: inducing 
healthy behaviors (69), changing activity and inactivity patterns (70), modifying eating 
habits (71), and promoting prevention through education programs for new parents (72).  
However, if interventions are targeted as a function of prevalence, then limited resources 
can be allocated proportional to the need. Targeting interventions geographically is one 
strategy, and thus identifying areas with children at higher risk for elevated body mass 
index (BMI) is crucial in delivering cost-effective interventions. Our study considers high 
BMI children those who are either overweight or obese. 
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Existing weight and height data used for the estimation of children’s BMI levels 
in the US has been obtained either through self-reports (which include parental reports), 
or through direct measurements on the surveyed individuals. For example, the National 
Survey of Children’s Health (NSCH) (73) provides state-level percentages of overweight 
or obese youths age 10-17 from self-reported information. The National Health and 
Nutrition Examination Survey (NHANES)(74) presents weight and height data from 
direct measurements on the sampled population, from which national estimations of 
childhood overweight and obesity can be calculated (75). The Youth Risk Behavior 
Surveillance System (YRBSS) estimates national, state, and large urban school district 
obese and overweight prevalence values based on self-reported height and weight in 
representative samples of students in grades 9–12 (76). 
For a number of reasons (e.g. displacement of human resources, use of measuring 
devices, etc.) estimation of high BMI prevalence through direct measurement is more 
challenging and costly than through questionnaire surveys, which can be performed 
remotely. On the other hand, self-reporting may induce additional inaccuracies in 
estimation of high BMI prevalence. Self-reported information is generally biased in 
groups of children younger than 12 years old (77), and there are no reasonable 
approaches for correcting this bias for accurate estimation of high BMI prevalence (78). 
For these young groups, direct measurement may provide the only reliable method to 
estimate high BMI prevalence (78). Therefore, estimating the BMI status for children in 
geographic areas without available direct measurement is a challenging problem. 
Some cities or states have begun initiatives to measure BMI in schools (79). In 
general, systemic measures from schools or local random samples are not available for 
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most small geographical areas, such as counties, school districts, zip codes, or census 
tracts, to use in the estimation of their high BMI prevalence.  Researchers can obtain 
geocoded data from NHANES after undergoing a review process (80); however, there is 
no direct access to these data for most stakeholders in public health and not all small 
geographical areas are included in their sampling. 
Because of the difficulties in using self-reported BMI data, and the shortage of 
small-area samples for children, the existing methodologies used to estimate (adult) 
obesity prevalence in small areas (81-84) cannot be applied. To address this limitation, 
we provide an approach that uses publicly available information for baseline estimation 
of high BMI prevalence in children; we accompany our point estimates with confidence 
intervals.  Our prediction model is similar to some found in (85); specifically, we build a 
logistic regression model using individual survey  data and complement it with a re-
sampling procedure for estimating the distribution of the model coefficients. The logistic 
regression is estimated using information for high BMI covariates in children 2-17 years 
old from the 2001–2010 continuous NHANES (74). This model is used to simulate the 
BMI status of individuals in a population by virtually generating population samples 
using data from the 2010 Census Summary File 1 (86) and specific searches in the 2010 
American Community Survey (87). 
Using publicly available data in the construction of this methodological approach 
may offer a wider opportunity for its application by others, including not only public 
health organizations but also stakeholders like healthcare providers. Since our approach is 
presented in the absence of local samples or information on existing interventions, we 
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call our estimations baseline prevalence estimates, in the expectation that they will 
eventually be replaced by estimators that include local sampling through direct measures. 
Approaches to the estimation of prevalence of certain health conditions, in small 
geographic-areas, and without the benefit of local sampling are not new. Usually, these 
approaches are split in at least two phases: building a generalized linear regression model 
from a representative survey, and then connecting the regression model to a specific 
population though its socio-demographic characteristics. Some of the main difficulties 
researchers encounter with the use of this type of approach are: Correctly capturing the 
distribution of the regression coefficients into the model, restrictions in the aggregation of 
the publicly available socio-demographic information in the small geographic areas, 
generating adequate confidence intervals for the prevalence estimation, and validation of 
the approach due to lack of local samples to compare to. For example, Messer et al. (88) 
benefited from being granted access to records with the detailed characteristics of the 
target population, but do not capture the distribution of the regression coefficients, and 
their confidence intervals are roughly estimated. Some use the geographic identifiers of 
surveys to obtain local samples (89), although these identifiers are usually of restricted 
access. Using geographic identifiers has become a popular approach for the estimation 
for adult obesity in small geographic areas (81, 82, 90). Some have used Bayesian 
simulation based software to estimate the uncertainty of their estimations (91, 92). 
Choy et al. (93) stress the relevance of using publicly available information, and 
build an estimation model for disease prevalence combining NHANES III and Census 
1990 data. Their results are validated showing significant correlations to related 
malignances, although the paper does not provide insights on the use of more recent (and 
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aggregated) census data or on the estimation of variability for the estimation. Other 
studies validate the use of generalized linear models to extrapolate national surveys into 
small geographical areas using Census 2000 data (94), but do not provide any guidance 
on how to deal with the common difficulties implied. 
Zhang, et.al(95) present a multilevel approach that uses restricted geo-coded data 
from the 2007 National Survey of Children’s health to predict childhood (ages 10 to 17 
years) obesity at the census block-group level. But, as noted by Longjohn et.al. (96), a 
transcending effort needs to be made to provide local BMI data on children 14 and below. 
 We predict high BMI prevalence for children within a small geographic region 
by simulating its virtual population at the individual level and predicting whether each 
individual has high BMI. We use the conditional distribution of high BMI probability 
derived from the regression model for the construction of the confidence intervals, and 
extract all data from publicly available sources. Therefore, our approach is a novel 
methodology for the estimation of baseline prevalence in small geographic areas without 
the use of restricted geographic identifiers and in the absence of available local samples. 
The development of our approach responded to the need of prevalence estimation 
for targeted interventions of a health care provider. This institution desired information to 
target a large scale campaign to improve children’s health conditions in Georgia, 
including interventions addressing the state’s childhood high BMI problem. This paper 
explains how the methodology is used to provide baseline estimations for the high BMI 
prevalence of their target population (children 2-17 years old) in Georgia, at the census 
tract level. Nonetheless, the same methodology can be applied to also generate baseline 
estimators at zip code, county or other geographic aggregation levels. With prevalence 
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mapped at the local level, we are able to identify areas where the greatest impact could be 
made in the state (based on prevalence and overall number of high BMI children), and a 
deployment strategy for the intervention is proposed. 
Below we present a more detail explanation of our methods, followed by the 
presentations of the results derived for the state of Georgia.  Finally, we will discuss the 
application, limitations, and advantages of our approach.  
Methods 
We develop a local-level high BMI prevalence model using NHANES continuous 
surveys (74). In this process, we merged data from 2001 to 2010. Then, we used 2010 
Census data to generate virtual populations. The model implementation uses R statistical 
software (58) to read the data files(97), manipulate data, choose the set of initial census-
based predictors, and generate samples from the distribution of a high BMI event based 
on the fitted logistic regression model(98), and to map the results(99). It also uses the 
C++ platform to simulate the prediction of high BMI prevalence at the census tract level. 
Below we present details on this methodology. 
Logistic Regression Model 
In fitting the logistic model, we observe (Xi ; Yi) for i = 1, … , N, for N 
individuals, where Yi are binary values specifying whether the i
th
 individual has high BMI 
and Xi = (Xi a, … , Xi h) is the set of covariates for the i
th
 individual. The regression 
problem is to estimate the probability of an individual to have high BMI given their 
characteristics represented by the set of predictors Xi, specifically, estimate Pr(Yi=1| Xi). 
The descriptions of the binary response Y and the set of covariates X are provided next. 
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As a comparison, we conducted an additional analysis using linear regression, which we 
present in Appendix D. 
Derivation of the dependent variable: Y 
We use the conventional calculation of the BMI as a person’s weight in kilograms 
divided by the square of their height in meters. The BMI-for-age charts adopted by the 
Centers for Disease Control and Prevention (CDC) in 2000 define our population 
percentiles (66). The present work considers that individuals have high BMI when their 
BMI reaches or exceeds the 85
th
 percentile. NHANES measures individual BMI values in 
the examination of interviewees. We therefore convert the BMI values into a vector 
consisting of binary values (equal to 1 when the individual has high BMI and 0 
otherwise). This variable is the dependent variable in the regression model.  
Model Covariates: X  
Based on the findings in the existing literature (100, 101), we use covariates 
related to socio-economic status and a number of other individual factors potentially 
related to high BMI. Some of the individual-characteristics variables reported by 
NHANES between 2001 and 2010 are also found in the publicly available information 
for census tracts in the 2010 Census. We consider variables common to both datasets and 
expectedly associated with high BMI for building potential covariates in the model. 
Examples of the variables considered are: gender, race/ethnicity, age, education level of 
the household reference person (person who owns or rents the residence where the 
members of the household reside(74)), household size, and income or poverty level. 
Table 1 summarizes the covariates considered. We test all the covariates in the iterative 
building of prospective models. We remove from the models those variables that are not 
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statistically relevant or not closely related to the publicly available census information. 
Table 4.1 summarizes the covariates considered. 
 
 















Implementation of the logistic regression model  
We linearly scale all variables into a [0,1] interval for numerical stability and 
comparison across covariates. We select the covariates using backward stepwise variable 
elimination. The final model includes covariates that: 1) significantly explain the 
variability in the response variable (p-value < 0.02); and 2) can be obtained through 
publicly available census tables (see complete list of census tables used in Appendix E).  
The fitted logistic regression provides estimates for the conditional distribution of 
Yi |Xi. The estimated model for Pr(Yi = 1 | Xi = x) is: 
Covariate Type Values Meaning 
Xb Binary {0, 1} Non-Hispanic Black (1) or not (0) 
Xnho Binary {0, 1} Non-Hispanic Other (1) or not (0) 
Xh Binary {0, 1} Hispanic (1) or not (0) 
X4 Binary {0, 1} Below 4 times poverty level (1) or not (0) 
X2 Binary {0, 1} Below 2 times poverty level (1) or not (0) 
X1 Binary {0, 1} Below poverty level (1) or not (0) 
Xg Binary {0, 1} Male (1) or Female (0) 
Xe Discrete {1, …, 5} Household representative education level 
(lesser to higher) 
Xh Discrete {2, …, 7} Household size 2 to 7 or more 
Xi Discrete {1, …, 11} Household income level (Increasing) 
Xa Continuous (24, 216) Age in months 
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 ̂                        
where H is the logistic regression function and            are estimated 
regression coefficients. In order to obtain a sample from the empirical distribution of  ̂ , 
or equivalently, from the empirical distributions of           , we use the bootstrap re-
sampling method.  Specifically, we repeat for 1000 times the following procedure: 
Divide NHANES data in ten random classes with equivalent number of samples 
in each.  
1. Removing one class at a time, fit the logistic model to the remaining 
sample of individuals to obtain a realization   
    
      
  from the empirical distribution 
of           . The sampled probability from the empirical distribution of  ̂  becomes 
 ̂ 
      
    
            
      . 
We use the sample from the empirical distribution of  ̂ in predicting the high BMI 
probability of a virtual individual which in turn is used to estimate high BMI prevalence 
within a geographic area based on its population composition. 
Simulation Model 
Generating virtual population with a geographic area 
Given a geographic area such as a census tract, we can obtain demographic and 
socio-economic data using publicly available data from the Census Bureau. These data 
can be used to generate a virtual population within that specific geographic area. This is 
equivalent to generating from the distribution of Xi = (Xi a, … , Xi h). In our simulation 
study, we obtain 1000 virtual individuals within each census tract by simulating from the 
distribution of population characteristics X. The generated characteristics of these 
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individuals are denoted by X
*
1, … , X
*
1000.  In our implementation, we focus on the 
census tract as our primary small-area of interest, although the methodology presented 
herein can also be used to analyze other unit areas including county or zip code.  
To be able to have a closer characterization of the population in a geographic 
area, we consider the possible interdependence of some of the population characteristics 
Xi a, … , Xi h. Specifically, we relate each of the census variables to the race/ethnicity 
groups by examining multiple tables provided by the Census. We find that, for example, 
the distribution in the household size for non-Hispanic Whites is different than that of 
Hispanics. Other interactions are not publicly available in the Census, and therefore, 
conditionally on race/ethnicity, the other variables are simulated independently of each 
other. 
Linking the individual high BMI regression model to small-area-level data  
Our simulation generates a virtual sample of the population living in a geographic 
area using census information and accounting for some of the interdependence in the 
population characteristics.  Specifically, for each virtual individual j (j = 1, … , 1000 in 
our implementation) we obtain  ̂ , the estimate of  Pr(Yj = 1 | Xj = X
*
j) by sampling from 
the empirical distribution of           , resulting in the realization    
     
       
 , and 
evaluating the logistic probability function in X
*
j, the personal characteristics  of the j-th 
virtual individual, calculating 
 ̂ 
      
     
    
        
    
  . 
To label each individual as high BMI or not, the probability of the j-th virtual 
individual is simulated from a Bernoulli random variable with probability  ̂ 
 , denoting 
the resulting label   
 . The high-BMI prevalence estimate is then 
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 ̂  
∑   
  
   
 
 
for B=1000 samples in our implementation. For each census tract, we also estimate the 1- 
  confidence interval for the high-BMI prevalence by repeating the simulation approach 
1000 times to obtain  ̂   ̂     ̂     samples from the distribution of high-BMI 
prevalence within the census tract and estimate a normal interval as 
( ̅    
 
√ ̂  ̅    
 
√ ̂)         ̅   
∑  ̂ 
    
   
    
      ̂   
 
   
∑( ̂   ̅)
 
    
   
  
It is important to remember that the sampling is performed on virtual individuals 
that depict the characteristics of the population and not on population members. 
Therefore, 1000 independent samples can be made even if actual communities have a 
children population of less than 1000 individuals.  
This simulation model allows for variations in the predicted probability  ̂ 
  due to 
estimation by using a realization of the estimated regression coefficients and due to 
individual randomness by simulating individual characteristics. The confidence intervals 
are estimated using a double re-sampling technique for more accurate estimation of the 
variance of the prevalence estimate. 
Application to Targeted Interventions 
When a limited amount of resources is assigned to improve an overall indicator of 
a system, a possible solution will be to allocate most of those resources to those 
components of the system that will render the largest overall benefit to that indicator. For 
our context, two indicators are relevant for the priority classification of small areas based 
on the severity of the childhood high BMI problem. The first is the estimated baseline 
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prevalence for the area as calculated. The second is the estimated number of high BMI 
children (the product of the estimated prevalence times the population of children) for 
each area.  
The commonly known Pareto principle(102) (which has to be taken with extreme 
care when used in relation to health) establishes the idea that when looking for the 
solution of the problems of a system, usually the largest proportion of the benefit is 
obtained from solving a proportionally small part of the problems. We use a variant of 
this Pareto-principle to select priority areas with the goal of selecting the census tracts 
with a larger number of high BMI children. We prioritize those census tracts that in total 
represent about 80% of the total population of high BMI children.  
Results 
Logistic Regression Model 
The logistic regression model we present includes six variables, three variables 
for encoding four race/ethnicity categories (Hispanic, Non-Hispanic Black, Non-Hispanic 
White, and Non-Hispanic Other), age of child in months, household size, and education 
level of household representative. The reference group for the regression is Non-Hispanic 
White in a household of size 2, age 2 years, and a household representative with lowest 
education level. The odds ratios (ORs) of the coefficients and the 95% confidence 
intervals of the ORs are shown in Table 4.2. All the p-values of the variables are less or 
equal to 2% and the p-value of the overall model is close to zero for all tests applied, 
including Wald F and Wald chi-square.  
As shown in the model and as found in NHANES data, Non-Hispanic Black 
children and Hispanic children are more likely to have high BMI than the reference 
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group, and Non-Hispanic Others are less likely. The model also indicates that the 
probability of having high BMI increases with age, and decreases with household size. 
High BMI is also less likely for children whose household reference person has higher 
education.   
 
 
Table 4.2: Adjusted coefficient estimates of the model for individual prediction (values 














The application of the simulation model is illustrated for the state of Georgia. In 
Table 4.3 we present the results for some counties and a few of their census tracts. It can 
be observed, for example, that census tract 20300 in the DeKalb County has a prevalence 
(0.27) that is significantly less than that of tract 20600 (0.36) in the same county (both are 
marked in the table), even though these census tracts are neighboring. Census tract 20300 
has a different ethnic composition from tract 20600 (84%, 4%, 4%, 8% and 8%, 89%, 
1%, 3% for non-Hispanic White, non-Hispanic Black, Hispanic, and Other non-Hispanic, 
Coefficient Covariate Estimate 95% C. I. Pr(>|t|) Characteristic 
β0 Intercept -0.444 (-0.683, -0.205) <0.001  
βb Xb 0.228 (0.115, 0.341) <0.001 Non-Hispanic Black or not 
βnho Xnho -0.239 (-0.420, -0.058) 0.011 Non-Hispanic Other or not 
βh Xh 0.342 (0.215, 0.469) <0.001 Hispanic or not 
βe Xe -0.612 (-0.788, -0.437) <0.001 Household representative 
education level 
βhs Xh -0.642 (-0.843, -0.440) <0.001 Household size 
βa Xa 0.613 (0.478, 0.748) <0.001 Age in months 
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respectively); comparable Family HH size (average 3.0); higher education of household 
representative (average 4.2 versus 3.7) and lower average age of children (7.5 versus 8.7 
years).  Also, Table 4.4 contains some examples of the prevalence for counties in 
Georgia. Differences among counties are observable, but not as strong as those for census 
tracts. For example, Early County has a higher mean estimation of baseline prevalence 
(0.37) than Oconee County (0.32).  
 
Table 4.3: Examples of census tract prevalence estimates in Georgia, with 95% 

























County  Tract  Mean  95% C. I.  
Cobb  31110  0.34  (0.301, 0.373) 
Cobb  31112  0.31  (0.276, 0.346)  
Cobb  31205  0.33 (0.293, 0.361)  
Cobb  31206  0.32  (0.285, 0.356)  
DeKalb  20300  0.27  (0.240, 0.308)  
DeKalb  20400  0.29  (0.251, 0.326)  
DeKalb  20500  0.38  (0.339, 0.412)  
DeKalb  20600  0.36  (0.324, 0.401)  
Fulton  400  0.30 (0.262, 0.332)  
Fulton  500  0.31  (0.273, 0.338)  
Fulton  600  0.33  (0.297, 0.369)  
Fulton  700  0.36  (0.323, 0.401)  
Muscogee  900  0.35 (0.314, 0.394)  
Muscogee  1000  0.34  (0.300, 0.373)  
Muscogee  1100  0.29  (0.255, 0.324)  




Table 4.4: Examples of prevalence estimates for counties in Georgia with 95% 























The estimated prevalence for high BMI at a census tract level in Georgia varies 
from 26% to 55%. The prevalence at a county level varies from 31% to 40%. According 
to the Census Bureau, census tracts are generally defined according to observable 
characteristics and features of the areas (103), while counties are usually larger and may 






Estimate  95% C.I. 
Appling County 13001 0.36 (0.320, 0.394) 
Bacon County 13005 0.36 (0.320, 0.392) 
Calhoun County 13037 0.37 (0.336, 0.410) 
Dade County 13083 0.34 (0.300, 0.372) 
Early County 13099 0.37 (0.328, 0.407) 
 Fannin County 13111 0.34 (0.305, 0.383) 
 Gilmer County 13123 0.35 (0.318, 0.390) 
Habersham County 13137 0.35 (0.312, 0.385) 
Irwin County 13155 0.36 (0.323, 0.393) 
Jackson County 13157 0.34 (0.300, 0.373) 
Lamar County 13171 0.36 (0.321, 0.390) 
McDuffie County 13189 0.37 (0.329, 0.403) 
Newton County 13217 0.35 (0.314, 0.385) 
Oconee County 13219 0.32 (0.282, 0.352) 




Figure 4.1: Map of baseline overweight children prevalence estimation in Georgia by 
census tract. Uses R software (58, 99) 
 
 
Figure 4.1 shows the map of the baseline prevalence estimation for census tracts 
in Georgia. On the map, darker colors indicate higher prevalence, while lighter colors 
indicate a lower prevalence. It can be observed, for example, that the north area of 
Atlanta has estimates of low prevalence, while some areas on the east, west, and south of 
the city have higher prevalence estimation. This knowledge is needed in the prioritization 
of populations to target interventions. Figure 4.2 shows a map with the estimated number 




Figure 4.2: Map of overweight children population by census tract in Georgia. Uses R 
software (58, 99) 
 
 
Application to Targeted Interventions 
When classifying communities for priority in the application of interventions we 
identified 77% of the high BMI children live in about 25% of the counties in Georgia. 
Figure 4.3 shows a map of prevalence in the 39 counties, from a total of 159, which 
account for the majority of children with high BMI in the state. Counties are marked in 
darker shades when they have higher estimated baseline prevalence. This map could 
provide a guideline to prioritize interventions, assuming that the desired objective is to 





Figure 4.3: Map of overweight children population prioritization in Georgia by county. 





We develop three additional analyses to validate our modeling approach: 1) we 
modeled the population 10 to 17 years old in Georgia, and compared our state-level 
outcome to the state-level prevalence estimate of the 2007 National Survey of Children’s 
Health (73). 2) We modeled the population of adults and compared our county-level 
results with the 2007 county-level obesity estimations for Georgia by the Diabetes Data 
and Trends of the CDC (104). 3) We modeled obesity for children 5 – 17 years old in the 
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counties in Arkansas and compared to the 2006-2007 school measurements in that state 
(105).  
Our result for the baseline prevalence estimation for high BMI children 10-17 
years old in Georgia was 37.5%. This result is comparable to the 2007 estimation 
presented by the National Survey of Children’s Health(73), which estimates the high 
BMI children (overweight or obese) prevalence to be 37.3% (31.7% – 42.9%) for 
Georgia. When comparing our county level results for adults in Georgia we obtain a 0.92 
spatial correlation with the 2007 county level obesity estimations from the National 
Diabetes Surveillance System (104). Appendix F contains the model used for adult 
obesity estimation. Finally, when comparing our county level obesity outputs for children 
5-17 to the 2006-2007 counties measurements in Arkansas (105) we obtain a spatial 
correlation of 0.78 with their estimates. 
Discussion 
The work presented has some intrinsic limitations. Our results do not substitute 
for the more complete measurement approaches available in some small geographic 
areas, which would also have the benefit of capturing effects of interventions. Our 
method is not helpful to capture the effects of locally applied interventions. Additionally, 
some small groups in census tracts do not have complete information available, adding 
levels of approximation to our approach in the smaller areas. It is difficult, if at all 
possible, to capture the complex nature of high BMI through modeling, which in the 
absence of local samples ties our approach to an unavoidable model bias. Our model is 
limited to the validity of the data used to build the model, and will not show the effects of 
changes in the population, unless they are included in the data. 
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Our model can only capture in a precise manner those interactions among 
population variables that are publicly available in the Census, introducing an increased 
variability into the estimation by considering independence among some of the input 
variables, as stated above. Many of the factors that relate to overweight in children may 
be area-specific and cannot be included in our model without the use of usually restricted 
geo-coded information.  
In the paper we describe a modeling approach that combines logistic regression 
modeling of individuals with bootstrap resampling and simulation of virtual sampling of 
the population.  Our approach allows us to estimate mean prevalence of overweight 
children as well as confidence intervals in many small areas. We built the models and 
populated the simulation intentionally with publicly available data so that the results 
could be repeated by others in the public health community. Sensible estimation 
differences found in a single county support the mentioned importance of estimating for 
small-areas. Validations indicate that our modeling methodology can provide reasonable 
estimates. Using our results and the proposed prioritization strategy, a local health 
provider in Georgia prioritized some interventions geographically across the state.   
The selection of the variables in the model such as the races/ethnicities discussed 
in the paper could change for different regions. For our analysis of Georgia we found that 
three main groups comprise the great majority of the population: Black, Hispanic and 
White. If this study is to be conducted in any other state, the selection of the model 
variables should match the social composition of the region under analysis, for example 
by representing Native Americans or Asians. 
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This method represents a viable and economic alternative for estimating the 
baseline prevalence of high BMI children. It can also be used for the estimation of 
baseline obesity (BMI ≥ 95%) prevalence for children or youths. Additionally, the 
approach can be generalized to estimate the prevalence of other diseases or conditions, 
especially when local samples are not available. 
We present a cost effective and sound alternative to the absence of local 
information that can be used to inform interventions against high BMI in children based 
on publicly available data. With appropriate caution, the prevalence rates generated 
through our model have served to build maps of baseline estimation of overweight 
prevalence in Georgia, and can certainly help build baseline estimations for other states 
or diseases without publicly available small-area estimates. Finally, our methodology 
could be easily expanded to consider additional area-specific values if geocoded 
information were available. This additional information would be expected to add 
strength to our estimations. 
Conclusion 
Valid and statistically sound baseline prevalence of high BMI (or overweight, or 
obese) can be estimated in small geographic areas, through publicly available data, for 
the guidance of local interventions in the absence of direct estimations. This approach 
was followed for the implementation of an intervention in Georgia, and can be used by 
any children’s health stakeholder in in the US. Future efforts include strengthening the 
approach by the inclusion of related covariates whose value is estimated at local levels, 
such as adult and youth overweight and obesity levels. Generalized regression models 
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allow many nonlinear forms which may capture more closely the relationship between 
covariates and prevalence, and can be used to strengthen this approach.  
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CHAPTER 5 
MODELING DISRUPTIONS TO FOOD SUPPLY CHAINS IN THE 
U.S. CAUSED BY ABSENTEEISM DURING A PANDEMIC 
 
Introduction 
During the onset of the Influenza Pandemic of 2009 many questions were posed 
respect to what would be the possible effects of such event in many dimensions. One of 
these questions was what could be the effect of the generalized disease caused by the 
novel H1N1 flu virus on the supply of critical goods, such as medical materials and food. 
To approach this question, this chapter presents a particular analysis on the supply chain 
of one food type. Given its generalized consumption, its relevant place in the nutrition of 
people of all ages in the U. S., particularly children, and its relatively traceable supply 
chain, drinkable milk was selected as an instance of food supply chains for the analysis. 
This study analyzes the level of disruption caused by absenteeism due to 
pandemic influenza, or other generalized flu-like illness, on a critical supply-chain in the 
U. S., and its consequences to the different echelon levels in it. The analysis also presents 
the effects of the disruptions under different inventory and slack capacity limits, and 
attempts to infer on the possible consequences of a number of proposed service policy 
scenarios. 
To perform this research we first found all possible relevant information related 
with milk production, processing, and consumption, using open sources on the internet. 
Then, with that information on hand, we built a generic supply chain. We fixed on it all 
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the clearly-identified detailed information and connections, and generated all the missing 
connections that would allow the product to flow from the producers to the markets. We 
use optimization to choose the arcs that would render a minimum cost (minimum 
distance) for that missing information. Next, we convert the completed supply chain into 
a network with capacitated arcs. Finally, we built a simulation of the flow of milk in the 
network, and used it to virtually disrupt the Supply Chain by reducing the flows 
proportionally to a simulated absenteeism in work groups, and calculate the effects of 
these disruptions. The details of our approach are contained below, after a presentation of 
the relevant literature.  
Literature Review 
Gaonkar and Viswanadham presented in 2004 a conceptual framework for the 
management of risk in supply chains (106). In it they described a classification of supply 
chain risk problems in 3 levels: the nature of the risk, the type of problem, and the 
planning level affected. According to its nature, our problem could be described as 
environmental; according with the type of problem, absenteeism could be categorized as 
a deviation, if it is mild, as a disruption if it would generate a total blockage of individual 
components of the network, and as a disaster if the SC would close (in this work we will 
always refer to them as disruptions); according with the planning level, the problem will 
usually affect the tactic level, although it could scale to the strategic level. 
Food supply chain disruptions due to diseases are mentioned in the literature as 
examples of potential disruptions (106). A specific framework for the design of robust 
food supply chains was developed by Vlajic et al. (107), where characteristics associated 
with food supply chains, such as seasonality of supply, seasonality of demand, and 
 65 
limited shelf-life, are presented as additional sources of vulnerability. They characterize 
disruptions (or disturbances) according to its size, as minor, major, or a failure. 
Influenza risk analysis (108), explain that the expected severity of flu-like 
illnesses could range from negligible (localized asymptomatic infections) to disastrous 
(pandemic with severe syndromes or death). For our analysis we will assume pandemic 
infections comparable to the 2009 H1N1 influenza. Large scale disruptions to food 
supply chains due to diseases in animals that are transmissible to humans are expected to 
have high economic impacts (109). But compared to that scenario, pandemic illnesses 
could cause disruptions due to absenteeism caused by generalized infections, which could 
affect simultaneously several food supply chains, potentially affecting the final delivery 
of all foods to the general population. 
BWE is first defined by Lee et.al (110) as a phenomenon where the variation of 
the orders placed to the supplier have a higher variation than the orders received from the 
customers. They also found that this effect is propagated and amplified upstream in the 
supply chain. Reverse BWE was defined by Rong et al. (111) as a similar effect 
propagating and being amplified downstream. Disruptions, understood either as a 
mismatch of forecast and demand at the lower end (final customers) of the supply chain 
(112), or as insufficient supply at the top (production) of the supply chain (113) have 
been related to the bullwhip effect (BWE) and the reverse bullwhip effect (RBWE), 
respectively. Although neither of these two causes directly relate to our problem, and we 
have not found literature relating disturbances to the internal connections of the supply 
chain to either of these effects, our preliminary results show bullwhip-like effects in our 
disrupted network. Also, disturbances to the flow of goods in the supply chain will 
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potentially generate supply and demand changes at each node of the network, which 
could generate a series of small BWE and RBWE (usually defined for sequential supply 
chains) along the entire network. For this reason, we review the BWE and RBWE 
literature, finding similarities and contrasts with other published materials. 
Behavior of supply chain actors, from producers to consumers, appears invariably 
among the causes of bullwhip in the literature, although not always with the same 
interpretation. One of the first accounts of the phenomenon was presented in 1958 by 
Forrester (114) blaming it on the “irrational behavior of actors in an SC” (115), while a 
Lee, Padmanabhan, and Seungjin (110) discovered that BWE occurs “despite the rational 
behavior of all the actors in the SC” (115). Our preliminary setup for the problem 
proposes “mechanical” rules for the flow of goods, expressed in the form of inventory 
level policies, ordering and allocation strategies, and redundant capacities, not attached to 
any behavioral rules for the participants. Still, we observe bullwhip-like effects. 
Rong, Snyder and Shen (111) concluded in 2008 that the sum of upstream and 
downstream bullwhip effects generated a larger variability in the orders at the center of 
the supply chain, and lesser at its extremes, forming what they called an “umbrella 
pattern”. They also presented in 2009 (113) that disruptions in the supply can cause price 
changes when there is a perceived shortage, which can in turn affect the demand. In our 
analysis we propose a different scenario, in which both ends of our supply chain are fixed 
through constant supply into the network and constant demand from the final consumers. 
The only disturbances affecting the behavior of the supply chain are the generalized 
disruptions caused by flu-induced absenteeism. What we observed in the preliminary 
results is that larger effects caused by the disruptions are observed in the middle echelons 
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of the supply chain, similarly to the mentioned bullwhip accounts. Following their sting 
metaphor that visualizes BWE and RBWE as small variations in one of the ends of the 
string being amplified towards the other end, our problem would show a string with both 
ends tied that grows variation from disturbances happening at places in the middle, more 
like a musical string or a vibrating trampoline than a bullwhip. 
Lee et al. suggest four main causes for the BWE, none of them directly relates to 
our problem (110). Pricing (113, 116) does not affect our initial approach either. Many 
other causes of BWE focus mainly on responses of the supply chain to a variable demand 
(117-119), which does not relate to our initial approach that considers a constant demand, 
but could relate to the sub-supply chains formed by subsets of nodes in our network. 
Disney and Towill (120) refer to the commonly used order up to level (OUTL) inventory 
strategy as a major cause of BWE, while Csik and Foldesi (121) show that a safety stock 
proportional to the demand will cause instability similar to BWE in sequential supply 
chains. For our first approach, we chose a simplistic inventory policy, consisting of a fix 
inventory target proportional to the long run demand. This could be a cause for the 
bullwhip-type effects we observe in our preliminary results. 
Collaboration and information sharing in the supply chain are shown to dampen 
BWE (122-124).  Order smoothing may work as a remedy as well (124). Our initial 
approach is a basic representation of the supply chain and does not consider these more 
advanced features yet. 
The great majority of modeling analyses on the bullwhip effect are done in 
sequential supply chains, which only have one player at each echelon of the chain. One 
study analyzes BWE in supply chain networks, in which members at different echelons of 
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the supply chain may interconnect with several other members, using frequency domain, 
a popular tool in the analysis of electronic circuits (125). One of the limitations of that 
analysis is that it does not consider capacities. Our proposed network is capacitated, and 
one of our decision parameters relates to capacity. 
We will finally mention that seasonal and pandemic influenza cause absenteeism 
to the labor force; and pandemic influenza has been shown to cause higher absenteeism 
than seasonal in other countries (126, 127). Both have a negative impact on the economy, 
and this impact could be aggravated if policies such as school closures are enforced (128, 
129). Our initial model only considers absenteeism in work groups caused by pandemic 
flu as simulated by Shi et al. (130), but does not consider absenteeism caused by policies. 
Methods 
Modeling the milk supply chain 
For the sake of isolating the effects due solely to generalized disruptions, we 
assume no seasonality for production and consumption, and no other fluctuations in 
demand as a first approach. Our model assumes that the same amount of milk enters the 
supply chain every period, and serves the same constant demand at each of the end nodes 
of the supply chain every period. Given that less than 1% of the milk consumed in the U. 
S. is imported, and that less than 28% of the total milk is actually used as drinkable milk 
(131), a continuous and stable flow of row material into the supply chain supply is not far 
from reality.  
For simplicity, we will assume that there is only one retailer at the center of each 
county in the U. S., which will supply all of its inhabitants with drinkable milk. We also 
assume that all milk drinkers will purchase the milk from the county retailer, at the end of 
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the supply chain, and not in any other point. We found detailed information for milk 
production at state level, but not always at county level. Whenever we have the counties 
where the milk is produced, we will use that information. We will allow the rest of the 
raw production in the model to gravitate close to the geographic center of their state. 
Although we are conscious that different industrial arrays may exist for producing 
milk (132), we will consider that all milk produced goes through 4 stages: Raw 
production, consolidation and conformation (e.g. pasteurization, homogenization, etc.), 
packaging, and retail. Whenever we found a processing center that encompasses more 
than one of these stages, we separate it into 2 independent processes with the same 
geographic location. 
To construct the supply chain we found the largest possible amount of 
information related with the actual network, and the location of the different processing 
sites. When connections between sites are explicit, they will be fixed as an existing edge 
by adding a lower bound to the edge. All unknown connections require the generation of 
all feasible interactions among the supply chain nodes. For example, if a raw producer is 
known to sell all of its production to a single consolidator, then that link is settled and 
there will not be a need to further connect that raw producer to other potential processing 
plants. But if knowledge about the destination of the raw milk of this producer is 
unknown, then we generate all possible connections between that producer and all 
feasible processing plants in the next echelon. Feasibility rules such as the maximum 
length between nodes are used. We use optimization to propose minimum cost 
connections that could plausibly fill in for the unknown interactions. We assume that 
each producer will likely prefer to deliver their product to the closest possible location of 
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the next echelon. In our case, since we are using days as the shipping and processing 
period, we will not allow the milk to move more than 650 miles between echelons, which 
is approximately equivalent to the maximum of 11 hours that by law a driver is allowed 
to run per day. 
The minimum cost approximation is adopted as the working supply chain. From it 
we will build a capacitated network. We assume that each of the three main 
manufacturing processes (all except retail) have a limited flow capacity that requires 
manpower to be operated, and that absenteeism will likely affect its operating capacity. 
To better model the capacity in these production nodes we split them in two parts. The 
link between them will represent the production flow inside these locations. Now, a 
capacity can be defined for each of the edges in the network. 
After splitting the production nodes, our three production echelons (raw 
production, consolidation and conformation, and packing) become six modeled echelons, 
two nodes for each real echelon. Adding retail, we obtain 7 simulated echelons. A 
complete graphical description of the milk supply chain network model is shown in 
Figure 5.1. The first sets of two nodes from left to right represent the raw milk production 
farms. The next two nodes represent the consolidation and conformation plants, followed 
by the two nodes representing the bottling and delivering functions. The far right nodes 
represent retail locations. Milk flows from left to right and information from right to left. 
Stars are used to exemplify partial disruptions occurring on edges. Table 5.1 presents the 
number of nodes at each echelon, which in total add to 4217. The total number of active 
edges in the supply chain adds to 4411. 
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The nominal capacity of the arcs is defined by their flow in the absence of 
disruptions, plus an additional slack percentage. We will discuss more about this slack 
capacity in the sections below. 
 






Table 5.1: Number of nodes at each echelon of the milk supply chain. 
 
Echelon Description Number of nodes 
0 Raw production IN 132 
1 Raw production OUT 132 
2 Consolidation and Conf. Plants IN 134 
3 Consolidation and Conf. Plants OUT 134 
4 Packing IN 288 
5 Packing OUT 288 
6 Retail 3109 
 Total 4217 
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Timing for information flow and product supply 
We assume that information will travel upstream, from one echelon to the next, in 
one period of time (for milk the period is assumed to be one day). Orders will be 
immediately supplied, but each of the downstream movements of product to the 
following echelon is assumed to last one full period. Purchase orders generated at each 
period will be received by the supplier in the same period, and the ordered product will 
be received in the next period. 
Ordering, inventory and service policies 
Our supply chain is assumed to be decentralized. Therefore, each of its parts will 
act independently of the others, according with its own established policies. This 
assumption poses a worst case scenario, given that collaborative supply chains can 
usually improve their reaction to variations (122-124). We believe this assumption may 
also be a closer representation to absenteeism due to a flu-like illness, which occurs 
randomly and suddenly and last a brief but random number of periods. These 
characteristics may avert the benefits of collaboration. 
A fixed inventory target level (a constant quantity to refill the stock up to) is 
adopted as the base approach to an inventory policy of all the nodes. Fixed target levels 
can result from having a constrained storage capacity or a defined maximum inventory 
level. Initially, we will fix the inventory target value proportional to the long term 
demand at each node. 
When there is more than one supplier, ordered quantities are split always in the 
same proportion, according to the long term demand. When more than one buyer, 
supplies meet last received order, except in the case when there is no sufficient inventory 
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to supply both requests. In that case, supply is shared proportionally to the requested 
quantity. In this case, no priority is established for the orders of the customers. Since we 
are considering lo seasonal effects, long term averages are considered equal to those 
quantities requested in the absence of disruptions and under equilibrium (at each node, 
flow in equals flow out, and all inventory levels reach their target value). 
Calculation of order quantities 
We assume supply chain events occur in the following sequence: 1) Previous 
period orders are received; 2) inventory levels are calculated; 3) orders from echelons 
down the supply chain are received; and 4) new orders are calculated and sent to 
suppliers. 
The calculation of the sum of orders   
  to be placed by node j in period t is as 
follows. Let   
  be the sum of shipments received in period t by node j; let   
  be the 
inventory level calculated at period t, at node j; let   
  be the sum of orders received by 
node j in period t; and let   
  be the sum of orders placed by node j in period t. Let      
represent the target inventory. Then:   
             
    
    
         
  . 
Disrupting the supply chain 
We use absenteeism groups generated by an agent based model that simulates 
possible infections due to interactions of individuals that belong to different groups (133). 
Using these groups' absenteeism outcomes from that model (ran for R0 = 1.3) allows us to 
randomly relate work groups in the Supply Chain with the simulated group's absenteeism 
outcome. We randomly assign different absenteeism behaviors to each edge. This will 
give a particular timing and acuteness of the disease, to each of the different work groups 
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in the milk's Supply Chain. Disruptions are caused by absenteeism in all milk processing 
sites (edges between duplicated nodes) and in their associated transportation service, this 
is, the working groups that transport goods between different processes (edges between a 
node out of one process and a node into the next process or retail). Disruptions are 
generalized along the entire network. 
As a first approach, no disruptions are considered for the final consumer or at the 
raw milk source. The assumption that there are no disruptions at the end consumer 
considers that illness will not affect the consumption behavior for this particular food 
item. The assumption that there will be no disruptions affecting the milk's input source 
acknowledges a much larger production of raw milk than that used for drinkable milk and 
a source (cows) unaffected by the pandemic. 
Simulation 
We constructed a Monte Carlo simulation program to randomly apply disruptions 
to the different arcs of the supply network using C++. Initially, we considered 10% to be 
a normal slack on transportation and processing capacities, which will enable the network 
to absorb small changes in the supply patterns. We will also consider an inventory level 
of two average periods, in this case two days of average demand, as the order-up-to 
quantity, at each of the processing sites. We simulate 1000 replications under these 
conditions, randomly assigning a different absenteeism group at each replication. Each 
replication simulates absenteeism for 180 days.  
Refining the simulation capabilities for a more elaborated approach, we changed 
the percentage of additional capacity available between 0 and 20%, on increments of 1% 
each time, keeping the order-up-to quantity fixed at 2 days. The simulation ran 1000 
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replications for each of these scenarios. We also allowed the simulation to keep the slack 
capacity at 10% while varying the order target inventory level between 1 and 3 days, 




Figure 5.2: Percentage of periods with unmet demand with 10% of slack capacity and 2 






Fixed slack capacity and target inventory levels 
We build a base case with 10% of slack capacity and 2 days of target inventory. 
After running a simulation for this basic case, we obtain the graph shown on Figure 5.2. 
Echelon 0 represents the cows, and echelon 6 represents retail. Notice that retailers (node 
6) experience the shortest average unmet demand to its customers. Changes in the 
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demanded quantities set by the independent decision makers in the different nodes of the 
network induce variability along the Supply Chain. Here, the demand to the retailer is 
assumed constant. Also, in the same figure we can appreciate that the largest percentage 




Figure 5.3: Variation on the percentage of periods with unmet demand when slack 
capacity is 10% and the target inventory is 2 days 
 
 
 The demand variability provoked by the disruptions is mainly experienced at the 
zeroth node. Figure 5.3 shows this increase in variability. 
The average accumulation of inventory (measured in days of inventory) at each 
echelon level reduces as the supply chain approaches the final consumer (see Figure 5.4). 






















































Variation on un-met demand 
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downstream in the supply chain, which increasingly restricts the flow of goods from one 




Figure 5.4: Average days of inventory accumulated at each echelon when slack capacity 





Figure 5.5: Average days of inventory accumulated at echelons 1 - 6 when additional 
capacity is 10% and the target inventory is 2 days 
 
 
On Figure 5.5 we focus our attention on echelons 1 through 6 (removing echelon 
0 from the graph). Notice that the change in the inventory level (measured in days of 
inventory) decreases monotonically. 
Finally, fixing both slack capacity and target inventory we calculate the average 
percentage of times that inventory level reaches zero at each echelon. Surprisingly we 
observe that the effect alternates from one node level to the next. Observing Figure 5.6 
we also appreciate that the greatest oscillations occur in one of the intermediate echelon 
levels. We notice that echelons 1, 3 and 5 have a single connection with echelons 0, 2, 
and 4, which are the input nodes to the 3 processes. Contrarily, each node in echelon 3 
connects in average with 2 nodes in echelon 4, and each node in echelon 5 connects in 
average with 11 nodes in echelon 6. The difference between the variance of a single 
connection as compared to the variance with multiple connections could cause this effect. 
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Notice that even though retailers in node 6 have a significant number of hits to 
zero inventory level, the difference between the supply and the constant demand does not 
add up significantly in the amount of unmet demand, as happens with any other node 




Figure 5.6: Average percentage of periods that reach an inventory level of zero when 
additional capacity is 10% and the target inventory is 2 days. 
 
Variable slack capacity level with fixed target inventory level 
When target inventory level is kept constant at 2 days of inventory, an increase in 
slack capacity (additional percentage of available capacity) causes the average inventory 
level to decrease in the first echelons. This is more notorious at echelon 0. Figure 5.7 
shows that when the additional capacity is reduced drastically, the inventory kept at the 
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initial echelon grows (because the restricted supply chain will not stop the constant 




Figure 5.7: Average days of inventory at different levels of slack capacity and target 




As additional capacity is decreased, the proportion of unmet demand grows for all 
echelons. But the growth in the unmet demand for echelons 4 and 5 is very steep, 
reaching around 70% for echelon 5 (see Figure 5.8). Surprisingly, the growth in the 
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proportion of unmet demand for echelon 6 is barely noticeable. Apparently, the unmet 
demand in the last echelon depends more strongly on the ordering-up-to policy (amount 
of safety stock), and not so much by the restricted flow that follows disruptions. 
 
 
Figure 5.8: Average percentage of unmet demand per echelon at different levels of slack 





The “trampoline effect” on the average number of times inventory drops to zero 
appears as the slack capacity drops below 15% and increases as the additional capacity is 
reduced (see Figure 5.9). As additional capacity is increased, the average number of times 
inventory hits 0 decreases for all echelons, except for the production node, which then 
has an increased flow of its inventory into the rest of the supply chain, and in turn renders 




Figure 5.9: Average count of periods that inventory reaches a zero level at different levels 




Fixed slack capacity level with variable target inventory level 
Now, we let the slack capacity of the system have a steady value of 10% while we 
move the target level of inventory between 1 and 3 days. When we do this, we find the 
realization of the intuitive fact that a greater amount of order-up-to days in the ordering 
policy will increase the average inventory; But not for all the echelons. Average 
inventory at echelon zero shows a convex behavior, with a minimum around 1.9 order-
up-to days, as can be appreciated on Figure 5.10. 
 
 




The fact that the proportion of unmet demand increases as the order-up-to days 
increases for the other echelons seems counter-intuitive. Why is it that the bigger the 
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stock the nodes want to form, the higher is the proportion of the unmet demand? That is 
because a greater request for a good that is produced at a constant rate will more likely 
generate orders that cannot be fulfilled by upstream echelons. However, notice on Figure 
5.11 that the proportion of unmet demand reduces for the final costumers, due to the pull 
effect that the entire supply chain is exerting towards the retailer. 
 
 




Once more the alternate effect in the number of zeros in the inventory level can be 
observed for most of the order-up-to levels. The greater the target inventory is, the more 
marked is the effect. The behavior of echelon zero differs when the target inventory 
reduces, but every other echelon increases rapidly (and still alternately) their count of 
zero level inventory periods (see Figure 5.12). 
 
 
Figure 5.12: Average count of periods with zero inventory level at a 10% slack capacity 




Discussion of preliminary results 
One of the most characteristic findings in the preliminary results is the observed 
“trampoline effect”, in which the number of times inventory hits zero forms a zig-zag 
pattern between echelons. The model clearly shows the big impact that generalized 
absenteeism may have on the overall performance of the supply chain, even when no 
explicit changes are applied to the total input or output of the system. It also confirms 
how small variations to the equilibrium of supply chains can cause extensive 
modifications to its behavior by the multiplying effect carried by the individual reactions. 
It is clear that this analysis can be applied to pandemic diseases of different 
severities and other similar disruptions from different causes, which gives added 
relevance to this study. 
Different echelons experience different consequences from the disruptions, and 
these do not always have a monotonic intensity through the supply chain. These 
differences may depend on the network array, given the number of connections a node 
may have coming into it, compared to the number of connections going out of it. 
Considering capacity by splitting the nodes of production facilities ads an 
interesting perspective of how internal connections in these plants play a relevant role in 












COMPREHENSIVE LIST OF ANALYZED VARIABLES 
POTENTIALLY RELATED TO H1N1 VACCINATION COVERAGE 
 
 The table below contains the list of factors analyzed in chapters 2 and 3 of this 
thesis. 










Group 1: Coverage measurements (Independent variables) 
y6 
Coverage on 
Children 6 mos. to 
17 yrs. 
MMWR (7) 38.9 11.9 84.7 21.3 
    
y7 
Coverage on 
persons aged ≥ 18 
yrs. 
MMWR (7) 19.9 5.3 34.4 8.7 
    
y8 
Coverage on 
persons aged ≥ 6 
mos. 
MMWR (7) 24.5 6.1 38.8 12.9 
    
y9 
Coverage on 
persons aged 25--64 
yrs. at high risk 
MMWR (7) 25.4 7.6 47.2 10.4 
    
Dependent variables 
Group 2: Population composition 
c0 
Resident population 
18 years and over, 
but under 65 years, 






56.2 2.1 63.1 50.2 
    
c1 
Resident population 
65 years and over, 




13 1.7 17.4 7.3 
    
c2 
Resident population 
5 - 17 years, percent 




24 1.9 31 18.9 
    
c3 
Resident population 
under 5 years, 




6.8 0.8 9.8 5.3 
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Black alone, percent 




11.4 11.1 54.4 0.7 
    
c5 
Resident population: 
Not Hispanic, White 
alone, percent (July 
1 2009 - estimate) 
Census 
(17) 
72.3 15.9 95.3 24.9 
    
c6 
Resident population: 
White alone, percent 




81.1 13.1 96.4 29.7 
    
c7 
Resident population: 
Hispanic or Latino 
Origin, percent (July 
1 2009 - estimate) 
Census 
(17) 
9.8 9.6 44.9 1.1 
    
c8 





7.3 5.6 26.2 1.1 
    
c9 
Population 5 years 
and over, percent 
speaking language 
other than English at 
home 2000 (sample) 
Census 
(18) 
12.7 8.8 39.5 2.7 
    
c19 
Resident population: 
American Indian and 
Alaska Native alone, 




1.8 2.9 15.3 0.2 
    
co4 
Population under 10 
years old, 2009. 
Census 
(17) 
13.5 1.4 18.78 10.66 
    
Group 3: Population economic and other social characteristics 
c10 
Educational 
attainment - persons 
25 years and over - 
percent high school 
graduate or higher 
Census 
(18) 
81.9 4.3 88.3 72.9 
    
c11 
Educational 
attainment - persons 
25 years and over - 
percent bachelor's 
degree or higher 
Census 
(18) 
24.1 4.7 39.1 14.8 
    
c12 
Average travel time 
to work for workers 
16 years and over 
not working at home 
Census 
(18) 
23.7 3.5 31.7 15.8 
    
c13 




37825 6594 62484 
2854
1     
c14 
Median Family 
Income in 2008 
Census 
(18) 
63715 9583 85761 
4666
8     
c15 





51557 7527 68175 
3757
9 
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People of all ages in 




12.7 3 20.7 7.3 
    
co1 
Calculation: Births 






1.4 0.2 2.1 1.1 







2.6 0.1 3.13 2.16 
    
co3 
Percentage of 




5.2 2.9 18.9 1.5 
    
co5 
Total number of 
separated, widowed 
and divorced people 
Census 
(135) 
0.13 0.02 0.17 0.08 








0.36 0.05 0.58 0.29 
    
ii2 
Income inequalities 
measured by the 
Theil's entropy index 
Volscho 
(2009)  (53) 
0.34 0.04 0.51 0.27 
    
ii3 
Income inequalities 





(2009)  (53) 
0.51 0.08 0.8 0.33 
    
ii4 
Income inequalities 
measured by the 
Gini index 
Volscho 
(2009)  (53) 
0.43 0.03 0.53 0.39 




Atkinson's Index with 
inequality aversion 
parameter e = 0.5 
Volscho 
(2009)  (53) 
0.16 0.02 0.24 0.13 
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Atkinson's Index with 
inequality aversion 
parameter e = 1.0 
Volscho 
(2009)  (53) 
0.3 0.03 0.44 0.26 




Atkinson's Index with 
inequality aversion 
parameter e = 2.0 
Volscho 
(2009)  (53) 
0.75 0.05 0.85 0.61 




of Dissimilation for 
all minorities - white 
James et al 
(2009)  (54) 
0.3 0.1 0.75 0.08 




of Dissimilation for 
black - white 
James et al 
(2009)  (54) 
0.4 0.1 0.82 0.1 




of Dissimilation for 
Hispanic - white 
James et al 
(2009)  (54) 
0.3 0.1 0.6 0.04 




of Dissimilation for 
Asian and NHPI - 
white 
James et al 
(2009)  (54) 
0.3 0.1 0.49 0.11 




James et al 
(2009)  (54) 
0 0.64 1.37 -1.73 
    
Group 4: State general characteristics 
pop 
Estimated total State 











    
c18 
Population per 
square mile 2000 
Census 
(17) 
362 1298 9378 1.1 
    
area 




74394 95725 663267 68 
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241.5 126.7 814.4 8.3 
    
lat Average latitude 
Census 
(17) 
39.5 6 61.4 21.1 
    
long Average longitude 
Census 
(17) 
-93.3 19.1 -69.4 
-
157.5     
nc 
Number of Counties 
in the state 
Census 
(17) 
61.6 46.4 254 1 
    




capita FY 2008 
Census 
(18) 
10680 9947 79757 6255 
    
hr 
1- Home Rule Local, 
2- Home Rule 
Mixed, 3- Home 
Rule State; Who 










2.5 0.7 3 1 
    
hrl 
1 if Localities hold 
governance of local 
health departments, 








0.1 0.3 1 0 6 45 
hrm 












0.3 0.4 1 0 13 38 
hrs 
1 if State holds 
governance of local 
health departments, 








0.6 0.5 1 0 32 19 
t1 
Total number of 
cars, trucks and 






0.8 0.2 1.19 0.36 
    
t2 
Number of driving 
licenses divided by 
population 
StateMaste
r.com (136)  
68.3 5.5 87.2 56.9 
    
tb 
1- State uses 




0.86 0.34 1 0 44 7 
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funding dedicated to 
public health as well 
as federal funding 
directed to states by 
the Centers for 
Disease Control and 










81.2 39.8 220.4 35.4 
    
ah22 
Medicaid 
expenditure in Long 
Term care 
(calculated as total 
Medicaid spending 
times percentage 
spent on long term 





2251 3274 20333 236 
    
ah23 
Medicaid 
expenditure in Long 





384 156 1041 143 
    
ah24 
Medicare enrollment 





15.5 2.2 21 9 




Seeing a Doctor in 
the Past 12 Months 




13 3.4 20.5 6.2 
    
ah3 







85.6 4.2 94.7 74.8 









27223 26983 109257 605 
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Population Living in 
Primary Care Health 
Professional 
Shortage Areas 





12.6 7.6 34.4 1.7 
    
ah30 
Certified Nursing 




32326 31862 123367 698 




State of Residence 




30417 32873 166236 2662 




State of Residence 





5191 830 8020 3454 










20.6 17.3 113 2 










48.3 7.5 64 29 
    
ch3 






91.6 3.5 97.3 80.6 
    
ch4 






63 7.8 76 46.6 
    
pr1 







24.45 4.38 43.27 16.75 









2.68 0.97 7.99 1.69 
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James et al 
(2009)  (54) 
0 0.74 1.58 -1.3 




James et al 
(2009)  (54) 
3.82 2.09 11.53 0.91 
    
whd5 
Percent of women 
living in a Primary 
Care Health 
Professional 
James et al 
(2009)  (54) 
0.44 0.08 0.61 0.22 
    
Group 7: Health conditions, adults 
ah1 
Adults who have 





8.7 1.2 11.1 6.3 
    
ah2 
Adults who have 
been told by a 





8.5 1.6 12.3 5.7 
    
ah4 
Good or better 




85 3.5 89.8 76.2 
    
ah5 
Weight classification 
by BMI as 
overweight [25-30) 
or obese [30+) 
BRFSS 
(26) 
63.4 3.6 70.2 51.7 
    
ah6 
Cumulative 
adolescent or adult 
AIDS cases reported 
CDC  (138) 17969 32859 170035 139 
    
ah9 






194 16.3 225.1 144.7 
    
ah10 
Cardiovascular 






283.6 38.7 378.5 212.6 











4.3 0.9 8.1 2.5 
    
ah12 
Percentage of adult 
population that has 






4.3 0.9 7.6 2.2 







among the Medicare 
population for 
diagnoses that are 
amenable to non-





71.4 15.9 109.3 29.3 
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464.4 32.5 536.1 394.1 
    
ah19 
Number of adults 










    
ah20 
Number of adults 
with serious mental 




3821 245 4258 3109 
    
ah21 
Number of Deaths 









42.7 6.4 57.4 28.2 
    
ah26 
Hospital Emergency 





429.2 92.1 740 275 
    
ah27 
Hospital Outpatient 





2316 826 5323 1115 
    
ah31 
Retail Prescription 
Drugs Filled at 
Pharmacies (Annual 
per Capita), 2009 
State 
Health (25) 
12.5 2.8 18.9 6.4 
    
ah32 
Total Retail Sales (in 
millions of dollars) 
for Prescription 





4258 4311 18908 350 
    
ah33 







730.9 146.9 1079.3 366.2 










8.9 1.9 14.7 5.9 
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261.1 50.2 411.2 133.1 
    
ah43 
Mortality with end-







26 7.7 52.5 13.8 
    
ah44 








341.6 55.7 451.3 183.8 




James et al 
(2009) (54) 
0 0.52 1.5 -0.85 
    
Group 8: Health conditions, children 
ch1 
General health  







2.8 1 6.2 1.2 
    
ch2 
Child has one or 






23 3 27.9 17.4 
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Group 9: Immunization coverage other than H1N1 
ah15 
The average of the 
percentage of 
children ages 19 to 
35 months who have 
received four or 
more doses of DTP, 
three or more doses 
of poliovirus vaccine, 
one or more doses 
of any measles-
containing vaccine 
and three or more 
doses of HepB 
vaccine. This does 
not measure if each 






77 4.3 85 65.5 
    
ah17 
Percentage of adults 
aged 65+ who have 





68.1 3 73.9 59.8 
    
ov1 
Children aged 19--
35 mos. with ≥4 
doses of DTaP, ≥3 
doses of poliovirus 
vaccine, ≥1 dose of 
any measles-
containing vaccine, 
≥3 doses of Hib 
vaccine, ≥3 doses of 
hepatitis B vaccine, 
≥1 dose of varicella 
vaccine in 2008 
MMWR 
(140) 
74.4 5.1 82.3 59.2 
    
ov2 
Teenagers with ≥2 
doses of measles, 
mumps, and rubella 
vaccine in 2008 
MMWR 
(141) 
89.2 5.3 99.5 73.2 
    
ov3 
Teenagers with ≥1 





toxoid, and acellular 





70.1 12.9 94.4 28.7 
    
sf1 
Seasonal Flu 
Coverage for high 
risk adults 18 -- 49 







32.8 7.5 50.8 14.3 
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Coverage for  adults 







55.4 11.5 80.5 27.3 




high risk adults 18 -- 







22.6 5.1 37.8 11.9 
    
sf3 
Seasonal Flu 
Coverage for  adults 







41.5 5.2 53.5 26.1 
    
sf4 
Seasonal Flu 
Coverage for  adults 







68.7 5 76.9 54.1 
    
sf5 
Seasonal Flu 
Coverage for high 
risk adults 18 -- 49 







37.5 5.7 54 22.3 
    
sf6 
Seasonal Flu 
Coverage for adults 







25.1 3.8 35.9 17.5 
    
sf7 
Seasonal Flu 
Coverage for adults 







44.1 4.4 53.7 34 
    
sf8 
Seasonal Flu 
Coverage for  adults 







73.2 4.4 81 60.8 
    
sf9 
Children 6 to 35 
mos. that received 




23.6 7.3 40.7 7.1 
    
Group 10: Use of preventive health services (other than immunizations) 
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Adults aged 50+ 
who have had a 
blood stool test 




21.2 3.6 29 9.1 
    
ah8 
Adults aged 50+ 





62.8 5.6 74.3 52.6 
    
ah16 
Percent of adults 
who responded they 
had visited the 
dentist or dental 
clinic within the past 





70.3 5.1 80.2 57.9 
    
ah36 
Percent of Women 
Age 18 and Older 
Who Report Having 
Had a Pap Smear 
Within the Last 




82.7 2.9 88.9 74.1 
    
ah37 
Percent of Women 
Age 40 and Older 
Who Report Having 
Had a Mammogram 





75.8 4.5 84.8 67.1 
    
ah38 
Percent of Women 
Age 50 or Older 
Who Report Ever 






62.4 5.6 73.2 51.8 
    
ch5 
Child had one or 
more preventive 





87.8 5.1 97.7 76.7 
    
ch6 
Child care meets the 






59.6 5.5 69.3 45.4 
    
Group 11: H1N1 Funding 
pf1 
FY 2009 Funding 
Total based on 2009 
Omnibus-enacted 




3.3 2.1 10.78 1.73 
    
pf2 




CDC (30) 3.25 0.9 5.97 2.38 
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Phases I and II % 
Unobligated through 
January 31, 2010 
CDC 
Report (29) 
0.22 0.21 0.72 0 
    
pf4 
Phase III % 
Unobligated through 
January 31, 2010 
CDC 
Report (29) 
0.28 0.26 0.95 0 
    
Group 12: H1N1 Epidemic 
pw1 
Peak week for 
number of ILI cases 




41.6 2.2 46 35 
    
pw2 
Peak number of 






0.41 0.36 1.69 0.06 
    
pw3 
Percentage of 
weeks with % ILI 





42 24.4 97.4 10.3 
    
pw4 
Percentage of 
weeks with number 
of cases above 1/3 




22.4 14.2 69.2 10.3 
    
pw5 
Number of weeks 
from peak until ILI 
dropped below 1/3 




5.9 3.9 21 2 
    
pw6 
Number of weeks 
from peak until ILI 
dropped below 1/2 




4 2.5 16 2 
    
Group 13: H1N1 CDC program 
alf 





0.48 0.06 0.71 0.41 
    
aln 





0.14 0.01 0.15 0.13 
    
dp1 
Driving mileage from 





742.4 612.3 3427 10 
    
dp2 
Depot is California 
(1) or not (0) 
Report 
CDC (3) 
0.2 0.4 1 0 10 41 
Group 14: H1N1 State program design 
um1 
Allocation decision 
level: 1- State, 2- 




1.75 0.93 3 1     
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Vaccine in public VS 
private sector. 1 = 
More Public, 2 = 
More Private, 3 = 





2.43 1.26 4 1     
um4 
Estimated 















0.34 0.47 1 0 17 34 
um9 
Estimated % of VCF 
providers who gave 
H1N1 vaccine: 0- 
DK or less than 
50%, 1- 50% to 





1.29 0.8 2 0     
um10 
Who determined 
allocation amount to 
private providers? 0- 




















0.26 0.44 1 0 13 37 
um113 
Third parties make 
transfer/redistributio




0.16 0.37 1 0 8 42 
um12 
Could state track 
vaccine to final site? 




0.4 0.49 1 0 20 30 
um131 
Early allocation 
strategy (first few 
weeks) was some 





0.16 0.37 1 0 8 42 
um132 
Early allocation 
strategy (first few 
weeks) was pro 




0.56 0.5 1 0 28 22 
um133 
Early allocation 
strategy (first few 
weeks) was focused 
on target 





0.26 0.44 1 0 13 37 
um14 
School-based clinic 
strategy: 1- School 




0.3 0.46 1 0 15 35 
umL 
1- if locals have the 
allocation decision, 




0.33 0.47 1 0 17 34 
umm 
1- if state and locals 
shared allocation 




0.08 0.27 1 0 4 47 
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1- if state has the 
allocation decision, 




0.59 0.49 1 0 30 21 








0.37 0.1 0.52 0.18 
    
o1 
Average number of 
days between 




4.7 2.2 9.2 0.5 
    
o2 
Average number of 






1.6 1.5 6 0.1 
    
pd 
Total Public Doses 






39.6 20.3 98.9 11.9 
    
ph 
H1N1 Vaccine 
Doses Distributed or 
Administered to 
Date from Large 
Pharmacy Chains / 
Retail-Based Clinics 
to States as of 
January 29, 2010 
CDC 
Report (57) 
10 6.6 30.1 0 
    
um3 
Status of School 
Clinics by Oct. 27: 1- 
Some clinics held, 2- 
Holding doses for 







2.43 0.81 3 1 




population by Dec. 









population by Dec. 





0.82 0.38 1 0 42 9 
um7 
Retail vaccination is 
used  by Dec. 18, 
2009: 2- Widely, 1- 
Moderated or in 





1.56 0.73 2 0 
    
Group 16: H1N1 Shipments 
o3 
Average number of 
Shipments per day 





40.2 45.3 223.6 0.5 
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Average number of 
doses per shipment 





773 1033.4 6365.7 222.4 





0.13 0.34 1.91 0.00
1
 
    
o6 
Percentage of days 
with shipments from 





53.7 12.1 71.6 19.4 
    
o7 
Average days from 
allocation to 




6.3 2.3 12.5 2.1 












0.5 0.25 1.18 0.02 
    
sh2 
Maximum number of 
ship-to sites per 






0.5 0.1 0.74 0.00
2
 
    
sh3 
Number of ship-to 
sites by unique 
combination of name 





0.16 0.08 0.3 0.0
3
 







3.98 2.96 19.64 1.56 
    
sh4 
Average number of 
days between orders 





3.02 1.06 8.14 1.44 
    
sh7 
Average of the 
absolute ratio of the 
differences between 
the county per capita 
doses shipped and 
the average per 
capita doses 
shipped to the state, 







0.58 0.87 6.29 0 
    




 Rounded value 
2
 Rounded value 
3
 Rounded value 
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Percentage of doses 
sent to primary care, 
MDs, counties, 
hospitals, urgent 






66.36 20.05 99.37 4.69 
    
sh9 
Percentage of doses 
sent to universities, 
military, jails, 
government, 





2.15 2.43 13.07 0.1 
    
sh10 
Percentage of doses 
sent to long care, 
internists, 
specialists, nursing 






7.8 6 27.44 0 
    
sh11 
Percentage of doses 







1.17 1.08 6.07 0 
    
sh12 
Percentage of doses 






47.76 25.83 99.37 0 
    
sh13 
Percentage of doses 







0.75 0.52 2.86 0.06 
    
sh14 
Percentage of doses 






6.69 5.25 22.16 0 
    
sh15 
Percentage of doses 






2.93 2.3 10.44 0 
    
sh16 
Percentage of doses 
sent to counties, 







57.34 21.93 99.37 13.15 
    
sh17 
Number of Ship to 
sites (by Name and 
Address) in 
November with 
respect to the 






0.97 0.88 4.36 0 
    
sh18 
Shipments per ship 
to site sent to other 







2.63 2.05 15 0.11 
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APPENDIX B 
VARIABLES HIGHLY CORRELATED WITH FACTORS IN THE 
ADULT MODEL 
 
 The table below provides examples of other variables highly correlated with those 
factors in the final adult’s model. 
 
Variable Description Examples of highly correlated variables ('+' is > 
0.5, '-' is < -0.5) 
Indep1 Percent of Women Age 18 and 
Older Who Report Having Had 
a Pap Smear Within the Last 
Three Years, 2008 
+ Percent of women who had a mammogram within the last two 
years 
+ Percent of Women who had a colorectal cancer screening 
+ Child had one or more preventive medical care visits 
- Percentage of population < 18 years old 
- Percentage of doses sent to counties 
Indep2 Resident population: Hispanic 
or Latino Origin, percent (July 1 
2009 - estimate) 
+ Total state population 
+ Chronic liver disease mortality 
- Proportion of children with medical home 
- Percentage of white population 
- Annual retail prescription drugs per capita 
- Child has health insurance 
Indep3 Average days from allocation to 
shipment of vaccine 
+ Average days between allocation and orders 
+ Average number of days between order and shipment 
- Shipments per ship-to site 
Indep4 Percentage of weeks with % ILI 
above 2.3, after week 30 
+ Mortality with end-stage renal disease  
+ Percentage reporting not seeing a doctor in the past 12 months 
because of cost 
+ Percentage of black population 
- High educational attainment 
- Proportion of children with higher insurance 
- Proportion of children with medical home 
- Good health status 
Indep5 Seasonal influenza Coverage 
for non-high risk adults 18 -- 49 
yrs. on the 2007-2008 season 
+ Other previous seasonal influenza coverage rates 
Indep6 Maximum number of ship-to 
sites per state per thousand 
population 
+ Resident population 65 years old and over  
+ Medicare enrollment as percent of total population 
- State's area 
Indep7 Percentage of doses 
categorized as sent to 
internists or specialists 
+ Percentage of doses sent to long care, internists, specialists, 
nursing homes, and children 
+ Number of ship-to-sites 
+ Percentage of doses sent to children 
- Percentage of doses sent to counties 
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APPENDIX C 
VARIABLES HIGHLY CORRELATED WITH FACTORS IN THE 
CHILDREN AND HIGH-RISK ADULT MODELS 
 
 The table below provides examples of other variables highly correlated with those 
factors in the final adult’s model. 
Variable Description 
Examples of highly correlated variables ('+' is > 0.5, '-' is 
< -0.5) 
Indep1 
Percent of Women Age 18 and 
Older Who Report Having Had 
a Pap Smear Within the Last 
Three Years, 2008 
+ Percent of women who had a mammogram within the last two 
years 
+ Percent of Women who had a colorectal cancer screening 
+ Child had one or more preventive medical care visits 
- Percentage of population < 18 years old 
- Percentage of doses sent to counties 
 
Indep6 
Maximum number of ship-to-
sites per state per thousand 
population 
+ Resident population 65 years old and over  
+ Medicare enrollment as percent of total population 
- Area of the state 
 
Indep8 
Percentage Reporting Not 
Seeing a Doctor in the Past 12 
Months Because of Cost 
+ Percent people in poverty 
+ General health condition fair/poor 
+ Deaths by stroke per 100,000 population 
- Have any kind of healthcare coverage 
- Percent of adults with dental visit in a year 
- Educational attainment at least high school 
 
Indep9 
Underserved Population Living 
in Primary Care Health 
Professional Shortage Areas, as 
of September, 2008 
+ Percent people in poverty 
+ Chronic liver disease mortality 
- Percent children with private insurance 
- Peak week for number of ILI cases after week 30 
 
Indep10 
Resident population under 18 
years, percent (July 1 - estimate) 
2008 
+ Percent of births to population 
+ Average persons per household 
+ Square root of state’s area 
- Per capita healthcare expenditure by state 
- Number of healthcare practitioners 
- Percent of women 40+ with mammogram 
 
Indep11 
Resident population: American 
Indian and Alaska Native alone, 
percent (July 1 - estimate) 2008 
+ Average days between shipments 
+ Area of the state 
+ Average number of doses per shipment 
 
Indep12 
Total Public Doses Oct-Feb 
divided by Estimated People 
Vaccinated 
- Percentage of days with shipments  
Indep13 
H1N1 Vaccine Doses 
Distributed or Administered to 
Date from Large Pharmacy 
Chains / Retail-Based Clinics to 
States as of January 29, 2010 
(no high correlations were found))  
Indep14 
Seasonal Flu Coverage for  
adults 18 -- 49 yrs on the 2007-
2008 season 
+ Previous seasons vaccination coverage  
Indep15 
Natural logarithm of the ratio of 
number of shipments to number 
of ship-to-sites 
+ Percentage of doses sent to counties 
+ Average days between shipments 




Examples of highly correlated variables ('+' is > 0.5, '-' is 
< -0.5) 
Indep16 
Percentage of doses sent to 
primary care, MDs, counties, 
hospitals, urgent care, clinics, or 
pharmacies. 
+ Square root of state’s area 
- Percent of women 40+ with mammogram 
- Adults 50+ with sigmoidoscopy or colonoscopy 
- Number of ship-to sites actually used 
- Percent of adults with dental visit in a year 
- Average travel time to work 
- Educational attainment at least high school 
 
Indep17 
Total number of cars, trucks and 
buses per capita 
- Average travel time to work 
- Percentage of children living with their grandparents 
 
Indep18 
Coverage expanded to general 
population by Dec. 4, 2009: 1- 
Yes, 0- No 
+ Deaths by stroke per 100,000 population  
Indep19 
School-based clinic strategy: 1- 
School Focus, 2- No 
+ Coverage expanded to general population by Dec. 4, 2009 
+ State makes transfer/redistribution to small providers 
- Determination of allocation amount to private providers made 
locally vs. state 
 
Indep20 
Third parties make transfer/ 
redistribution to small providers 





COMPARISON FOR OBESITY ESTIMATION USING LINEAR 
REGRESSION 
 
As a mean to validate the use of logistic regression versus linear regression, we 
repeated the methodology presented in Chapter 4 using linear regression modeling, for 
the adult obesity prevalence at a county level in Georgia. We started with the same set of 
variables used for the adult validation (Appendix F), and performed the variable selection 
process to build a significant model. The resulting linear regression model is presented in 
the Table below. 
 
Table D.1: Linear regression model for adults 
Age 
group  
Intercept BNH HIS ONH EDU HHS AGE Gender ERA 
18-24 
Estimate 25.71 1.65 0 -1.38 -0.61 0 0.49 0.58 0 
SE 0.45 0.29 0 0.5 0.12 0 0.05 0.23 0 
p-value 0.0000 0.0000 NA 0.0076 0.0000 NA 0.0000 0.0136 NA 
25-34 
Estimate 28.27 2.82 1.18 -1.02 -0.41 0 0.1 0 0 
SE 0.51 0.34 0.33 0.42 0.1 0 0.04 0 0 
p-value 0.0000 0.0000 0.0007 0.0183 0.0002 NA 0.0106 NA NA 
35-44 
Estimate 29.41 2.07 0 -2 -0.42 0 0 0 0.24 
SE 0.43 0.29 0 0.46 0.09 0 0 0 0.08 
p-value 0.0000 0.0000 NA 0.0000 0.0000 NA NA NA 0.0023 
45-54 
Estimate 29.91 1.97 0 -1.86 -0.28 0 0 0 0 
SE 0.42 0.29 0 0.48 0.11 0 0 0 0 
p-value 0.0000 0.0000 NA 0.0002 0.0125 NA NA NA NA 
55-64 
Estimate 29.88 1.45 0 -3.02 -0.37 0 0 0.64 0 
SE 0.56 0.34 0 0.61 0.11 0 0 0.25 0 
p-value 0.0000 0.0000 NA 0.0000 0.0014 NA NA 0.0114 NA 
>=65 
Estimate 29.6 1.4 0 -3.34 -0.22 0 -0.15 0 0.26 
SE 0.38 0.26 0 0.61 0.08 0 0.02 0 0.07 




Using simulation, as in Chapter 4, we obtain the adult obesity estimation using 
linear regression to predict BMI of the individual. To decide whether an individual is 
obese or not, we compare the simulated BMI with 30 (BMI limit used to determine 
obesity in adults), and classifying the individual as obese if the estimation is greater than 
this limit value. A graph comparing the confidence interval to the estimation conducted 




Figure D.1: 95% Confidence interval for obesity adult estimation at a county level in 





When compared to the county level values obtained by the CDC surveys, we 
observe that the linear model overestimates high obesity levels and underestimates low 
obesity prevalence. While the average linear estimation of prevalence ranges between 3% 
0
0.65















and 56%, the surveyed values range between 23% and 37%. The county-level adult 
estimations of the logistic regression approach presented in chapter 4, and adjusted by the 
state average, are compared to the CDC’s county level estimates in the figure below. 
 
 
Figure D.2: 95% Confidence interval for obesity adult estimation at a county level in 





 We observe that most of the CDC’s county level estimations fall within the 95% 
confidence interval of the logistic regression estimation adjusted by the state average. We 
conclude that the use of logistic regression in our simulated estimation offers a better 
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LIST OF CENSUS TABLES USED TO OBTAIN INFORMATION OF 
SMALL GEOGRAPHIC AREAS 
 
 
A. For Household Size: 
From Census 2010 summary file 1, we created files with Household size 
information for each of the following races/ethnicities: 
a. Total population 
b. Hispanic 
c. White Non-Hispanic 
d. Black 
Each of these files contained the following areas, in the given order: 
a. US 
b. State (GA) 
c. Counties in the state 
d. Census tracts in the state. 
Tables used are: 
PCT0280001 Households: Total 
PCT0280002 Households: Family households 
PCT0280003 Households: Family households; 2-person household 
PCT0280004 Households: Family households; 3-person household 
PCT0280005 Households: Family households; 4-person household 
PCT0280006 Households: Family households; 5-person household 
PCT0280007 Households: Family households; 6-person household 
PCT0280008 




B. For Education Level: 
From the American Community Survey, we created files with projections for 
2010 Educational attainment information for each of the following races/ethnicities: 
a. Total population 
b. Non-Hispanic 
c. Hispanic 
d. White Non-Hispanic 
e. Black Non-Hispanic. 
Each of these files contained the following areas, in the given order: 
f. US 
g. State (GA) 
h. Counties in the state 
i. Census tracts in the state 
The table used is B15001. 
C. For Age: 
1. From Census 2010 summary file 1, we created excel files with Age information 
for each of the following races/ethnicities: 
a. Total population 
b. Non-Hispanic 
c. Hispanic 
d. White Non-Hispanic 
e. Black Non-Hispanic. 
Each of these files contained the following areas, in the given order: 
 113 
f. US 
g. State (GA) 
h. Counties in the state 
i. Census tracts in the state 
The used tables are: 
PCT0120005 Total population: Male; 2 years 
PCT0120006 Total population: Male; 3 years 
PCT0120007 Total population: Male; 4 years 
PCT0120008 Total population: Male; 5 years 
PCT0120009 Total population: Male; 6 years 
PCT0120010 Total population: Male; 7 years 
PCT0120011 Total population: Male; 8 years 
PCT0120012 Total population: Male; 9 years 
PCT0120013 Total population: Male; 10 years 
PCT0120014 Total population: Male; 11 years 
PCT0120015 Total population: Male; 12 years 
PCT0120016 Total population: Male; 13 years 
PCT0120017 Total population: Male; 14 years 
PCT0120018 Total population: Male; 15 years 
PCT0120019 Total population: Male; 16 years 
PCT0120020 Total population: Male; 17 years 
PCT00120109 Total population: Female; 2 years 
PCT00120110 Total population: Female; 3 years 
PCT00120111 Total population: Female; 4 years 
PCT00120112 Total population: Female; 5 years 
PCT00120113 Total population: Female; 6 years 
PCT00120114 Total population: Female; 7 years 
PCT00120115 Total population: Female; 8 years 
PCT00120116 Total population: Female; 9 years 
PCT00120117 Total population: Female; 10 years 
PCT00120118 Total population: Female; 11 years 
PCT00120119 Total population: Female; 12 years 
PCT00120120 Total population: Female; 13 years 
PCT00120121 Total population: Female; 14 years 
PCT00120122 Total population: Female; 15 years 
PCT00120123 Total population: Female; 16 years 





MODEL FOR VALIDATION IN ADULT POPULATION 
 


































































Mean -1.61 0.54 0 0 -0.19 0 0.14 0.33 0 

















Mean -1.4 0.78 0.3 0 -0.11 0 0.04 0.25 0.07 









- 0.006 0.003 0.02 
35-
44 
Mean -0.43 0.44 0 -0.67 -0.12 0 0 0 0.07 








- - - 0.005 
45-
54 
Mean -0.36 0.42 0 -0.67 -0.11 0.05 0 0 0 







0.001 0.048 - - - 
55-
64 
Mean -0.36 0.35 0 -0.95 -0.09 0 0 0.19 0 








0.019 - - 0.012 - 
≥6
5 
Mean -0.5 0.51 0 -1.08 -0.08 0 -0.05 0 0.13 
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0.001 
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